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The Road not Taken
Two roads diverged in a yellow wood,
And sorry I could not travel both
And be one traveler, long I stood
And looked down one as far as I could
To where it bent in the undergrowth;
Then took the other, as just as fair,
And having perhaps the better claim,
Because it was grassy and wanted wear;
Though as for that the passing there
Had worn them really about the same,
And both that morning equally lay
In leaves no step had trodden black.
Oh, I kept the first for another day!
Yet knowing how way leads on to way,
I doubted if I should ever come back.
I shall be telling this with a sigh
Somewhere ages and ages hence:
Two roads diverged in a wood, and I -
I took the one less traveled by,
And that has made all the difference.
Robert Frost (1920)
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Zusammenfassung
Das Typ III Sekretionssystem (T3SS) ist ein makromolekularer Proteinkomplex den Gram-
negative Bakterien nutzen um in einem Schritt Effektorproteine (Effektoren) aus dem Zytosol
über die Doppelmembran zu sekretieren. Für viele Bakterien ist das T3SS ein essenzieller
Virulenzfaktor, der es ihnen erlaubt mit ihrem Wirt zu interagieren und diesen zu manip-
ulieren. Charakteristisch für das T3SS ist die membrangebundene strukturelle Komponente,
der sogenannte Nadelkomplex. Der Nadelkomplex ähnelt in seiner Struktur einer Spritze,
deren Basalkörper die bakteriellen Membranen und das Periplasma durchspannt und einer
Nadel, die vom Basalkörper aus dem Bakterium hervorragt. Basierend auf dem Modell einer
Spritze wird angenommen, dass Effektoren entfaltet und anschließend durch Basalkörper
und Nadelkanal sekretiert werden. Trotz der kontinuierlichen Forschung an T3SS entbehrt
dieses Modell einer experimentellen Grundlage und der Sekretionsmechanismus ist nicht
vollständig erklärt.
Ziel der Arbeit war es, eine experimentelle Basis für den Sekretionsmechanismus des
T3SS zu schaffen um die Funktionsweise des T3SS besser zu erfassen. Um zu verstehen, wie
das T3SS Effektoren sekretiert, wurden zunächst Fusionsproteine konstruiert, welche aus
einem Effektor und einem stabil gefalteten Knotenprotein bestehen. Die Effektorfunktion
wird durch die Fusion nicht beeinflusst und der Knoten faltet nativ innerhalb des Fusion-
sproteins. Aufgrund der Position des Knotens in der Fusion ist davon auszugehen, dass der
Knoten während der Sekretion nicht entfalten kann. Die Effektordomäne wird sekretiert, der
Knoten verbleibt jedoch im Kanal und verstopft das T3SS. Zusätzlich wurden die blockierten
Nadelkomplexe mittels Immunodetektion im Elektronenmikroskop untersucht und das Fu-
sionsprotein am isolierten Nadelkomplex lokalisiert. Nach dem derzeitigen Stand der Forschung
und unserem Wissen ist diese Arbeit die erste Visualisierung von Effektorfusionen an isolierten
Nadelkomplexen. Die Effektorfusion wird N-terminal voran durch den Kanal sekretiert, wobei
der Kanal das Substrat umschließt und gegen Proteasen und chemische Modifikationen ab-
schirmt. Die Ergebnisse dieser Arbeit untermauern ein elementares Verständnis über die
Funktionsweise des T3SS und liefern eine vielversprechende Strategie für zukünftige in situ-
Strukturanalysen. Dieser Ansatz lässt sich auch auf andere Proteinsekretionssysteme über-
tragen, bei welchen Substrate vor dem Transport entfaltet werden müssen.
Abstract
The Type III Secretion System (T3SS) is a macromolecular complex used by Gram-negative
bacteria to secrete effector proteins from the cytoplasm across the bacterial envelope in a
single step. For many pathogens, the T3SS is an essential virulence factor that enables the
bacteria to interact with and manipulate their respective host. A characteristic structural fea-
ture of the T3SS is the needle complex (NC). The NC resembles a syringe with a basal body
spanning both bacterial membranes and a long needle-like structure that protrudes from the
bacterium. Based on the paradigm of a syringe-like mechanism, it is generally assumed that
effectors are unfolded and secreted from the bacterial cytoplasm through the basal body and
needle channel. Despite extensive research on T3SS, this hypothesis lacks experimental ev-
idence and the mechanism of secretion is not fully understood.
This work aimed to provide an experimental basis for the model of the T3SS mechanism
for a better comprehension of how secretion by T3SS works. In order to elucidate details
of the effector secretion mechanism, fusion proteins consisting of an effector and a bulky
protein containing a knotted motif were generated. The functionality of the effector do-
main within the fusion was tested, as well as the folding status of the knotted domain. It is
assumed that the knot cannot be unfolded during secretion of the chimera. Consequently,
these fusions are accepted as T3SS substrates but remain inside the NC channel and obstruct
the T3SS. Furthermore, the obstructed T3SS channel was analyzed by immuno-labeling com-
bined with electron microscopy. This is, to our best knowledge, the first time effector fusions
have been visualized together with isolated NCs and it demonstrates that effector proteins
are secreted directly through the channel with their N-terminus first. The channel physi-
cally encloses the fusion protein and shields it from a protease and chemical modifications.
These results corroborate an elementary understanding of how the T3SS works and provide
a powerful tool for in situ-structural investigations in the future. This approach might also be
applicable to other protein secretion systems that require unfolding of their substrates prior
to secretion.
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1 Introduction
1.1 Shigella - a model for type III secretion
Shigella are the causative agent of bacillary dysentery (Shigellosis). They are Gram-
negative γ-proteobacteria which are rod-shaped, non-flagellated and thus non-motile (Peng
et al., 2009). The genus Shigella contains four species, namely S. dysenteriae, S. flexneri, S.
sonnei and S. boydii, all of which are able to cause disease in humans which are Shigellas only
natural hosts. First descriptions date back to the late 19th century where the Japanese scien-
tist Kiyoshi Shiga reported a bacterium being responsible for a dysenteric epidemic with over
89.000 cases of which more than 22.000 were fatal. Shigella are very similar to Escherichia
coli, but were classified into a different genus because of their medical significance in the
1940s. In fact, they are so similar that sequence analysis revealed Shigella being clones of
E. coli species and that enteroinvasive E. coli and Shigella share a common pathovar (Lan &
Reeves, 2002). Although distinct phylogeny is kept merely for traditional and medical rea-
sons, bacteria will be regarded as independent species throughout this work.
The lack of clean water, hygiene and malnutrition are contributing factors to higher in-
cidents in developing countries. In addition, the bacteria are highly contagious: oral up-
take of 10-100 bacteria is sufficient to cause disease (DuPont et al., 1989), which is at least
partially because of their resistance to acidic conditions (Gorden & Small, 1993; Jennison &
Verma, 2007). With regards to acquisition of antibiotic resistances (von Seidlein et al., 2006;
Shiferaw et al., 2012), infections with Shigellae are in need for alternative medical strategies,
especially since there is no vaccine available yet (Sansonetti, 2006; Phalipon et al., 2008).
In the developed world, S. sonnei is the predominant isolate (77% of all cases) whereas S.
flexneri is endemic in developing countries and the most frequent isolate of bacillary dysen-
tery worldwide (WHO on diarrhoeal diseases/Shigellosis, 2009). Shigella-caused dysentery
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is characterized by an inflammatory response with major pathology in the colon and rectum
where the bacteria invade the epithelial cells (Sansonetti et al., 1999). As the epithelial lining
is protected by a thick layer of mucus and a brush border, bacteria cannot enter directly from
the lumen through the apical side but have to cross the epithelium and infiltrate epithelial
cells from the basolateral side.
1
2
3
Figure 1.1: Early steps in Shigella flexneri infection. Bacteria (orange) traverse the epithelial cell line
(white) through M-cells (blue, 1) where they encounter macrophages (grey). The bacteria then escape the
phagolysosome and induce pyroptosis (2). Subsequently, bacteria evade the macrophage and enter the ep-
ithelial cells from the basolateral side, where they hijack the actin network for actin-based motility (3).
Three major steps take place before invasion of epithelial cells by S. flexneri: First, bac-
teria cross the epithelium through microfold cells (M-cells) that constantly sample macro-
molecules and bacteria from the gut lumen (Wassef et al., 1989; Perdomo et al., 1994)(Fig.
1.1, 1). Next, resident macrophages engulf the bacteria which subsequently escape the
phagosome and activate Caspase-1. By induced cell death, the bacteria evade phagocytic
killing (2) (Zychlinsky et al., 1992, 1994; Schroeder & Hilbi, 2008; Senerovic et al., 2012).
Membrane disruption of macrophages leads to release of mature Interleukin-1β, thereby
stimulating the inflammatory response. As a consequence, tissue destruction further desta-
bilizes the epithelial lining which in turn favors bacterial infiltration of the lamina propria
(Perdomo et al., 1994). The bacterium invades the epithelium by stimulating phagocytosis
(High et al., 1992), escapes the phagosome and hides inside the cytoplasm of epithelial cells.
After entering from the basolateral side, bacteria spread intracellularly to neighboring cells
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by hijacking the actin-network of the host. This exploitation of host factors is displayed by
the formation of actin tails which confer motility to the bacteria (Fig. 1.1, 3) (Mounier et al.,
1992; Vasselon et al., 1992; Prevost et al., 1992). Once inside a host cell, S. flexneri repli-
cates remarkably fast with a doubling time of 40 min, pointing out the efficient adaptation of
the bacterium to the host environment (Sansonetti et al., 1986; Ray et al., 2009).
Most of these steps depend on a functional Type III Secretion System (T3SS) which is
encoded on an extrachromosomal 200 to 220 kb plasmid (Venkatesan et al., 2001; Buchrieser
et al., 2000). This plasmid is present in all virulent Shigella flexneri isolates (Sansonetti et al.,
1982). Specifically a 31 kb core region, called the entry region, is indispensable and sufficient
for invasion of epithelial cells (Maurelli et al., 1985). This region encodes genes for structural
components of the T3SS, most of the substrates, chaperones and regulators. Apart from
its role as a highly prevalent human pathogen, Shigella flexneri is a model organism for
understanding the T3SS.
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1.2 Type III Secretion Systems:
Syringes mediating bacterial virulence
The T3SS is metaphorically described as a molecular syringe that S. flexneri and other
Gram-negative bacteria use to inject effector proteins into their hosts (Fig. 1.2). The T3SS
enables delivery of effector proteins into eukaryotic cells and is an important instrument
in host-pathogen interaction (Cornelis, 2006; Galan & Wolf-Watz, 2006). Some of the worst
pandemics in human history, for example plague and cholera, were caused by bacteria that
are known to utilize a T3SS. Recently, the T3SS has been also focused on as it might serve
as a target for novel anti-infective therapies (Clatworthy et al., 2007).
bacterial
cytoplasm
host
cytoplasm
e ectors
Figure 1.2: Paradigm of type III secretion. Bacterial effector proteins (blue) are secreted across the bacterial
membrane (orange) and injected into the host cell (light blue). The T3SS (syringe) forms a continuous channel
connecting both cytoplasms.
More than 20 years ago, the T3 secretion pathway was discovered by analysis of Yersinia
outer proteins (Yops) as it was distinguished from the type I transporters and the sec-dependent
type II pathway (Salmond & Reeves, 1993). The independence from a Sec-signal peptide as
seen for type I but also the dependency on a different gene cluster for secretion like type II
secretion led to the definition of a third bacterial secretion pathway.
By the end of the 20th century, the structural component had been identified in Salmonella
and Shigella and isolated from the bacterial envelope (Kubori et al., 1998; Blocker et al.,
2001). This syringe-like needle complex (NC) is the structural hallmark of the T3SS pathway.
The T3SS bridges the gap between the bacterium and the host cell as it is thought to provide
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1 µm
Figure 1.3: Type III needle complexes in the bacterial cell wall. Artificially coloured transmission electron-
micrograph of a bacterial cross-section. The needle complexes embedded into the bacterial membranes (orange)
are highlighted. Image courtesy of Ulrike Abu Abed, Diane Schad and Michael Kolbe.
a continuous channel between the bacterial and host cytosol (Büttner & He, 2009). Consist-
ing of more than 25 structural proteins, the syringe is a complex export system spanning the
bacterial membranes and the periplasm (Fig. 1.3).
Both pathogens and symbionts use T3SS to establish a trans-kingdom relationship with
one or more eukaryotic organisms by secreting proteins via the T3SS pathway, which are
stored in the bacterial cytoplasm prior to secretion (Hueck, 1998; Soto et al., 2006; Preston,
2007; Büttner & He, 2009). These proteins are collectively termed effectors, which includes
general effectors that target pathways in the host cell, and translocators that play an ad-
ditional role in effector translocation into the host cytoplasm. Effectors are thought to be
delivered unidirectionally in a single step into the host cytoplasm, where they then manipu-
late host cell biology, metabolism and defense pathways (Rosqvist et al., 1994; Ghosh, 2004;
Dean, 2011).
T3SS are thought to have appeared in bacteria just after the evolution of eukaryotes as
these systems are dedicated to trans-kingdom interaction (Troisfontaines & Cornelis, 2005).
Since then, the T3SS have been shaped by evolution depending on the pathogens or sym-
bionts niche. The T3SS was most likely spread by horizontal gene transfer, resulting in a
phylogeny tree completely different from the 16S rRNA-based tree which assigns bacterial
phyla. The T3SS is very similar to the flagellar apparatus in Gram-negative bacteria and it
is assumed that both systems share a common ancestor (Galan & Collmer, 1999; Erhardt
et al., 2010). Based on sequence analysis of non-flagellar and flagellar T3SS proteins, seven
T3SS subfamilies have been identified (Troisfontaines & Cornelis, 2005). Despite the distribu-
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tion of T3SS among bacteria living under completely different environmental conditions, the
principle of effector secretion through the NC is thought to happen by a common mechanism.
1.2.1 Architecture of T3SS
The NC structure is remarkably conserved among the T3SS-positive bacteria. Of the
seven structural families, the Inv-Mxi-Spa subfamily including T3SS from S. flexneri and
Salmonella enterica and the Ysc subfamily from Yersinia have been extensively studied (Tro-
isfontaines & Cornelis, 2005). Cryo-EM analysis of the NC structure of Salmonella enterica
serovar Typhimurium SPI-1 and S. flexneri revealed structural details up to subnanometer
resolution (Schraidt & Marlovits, 2011; Hodgkinson et al., 2009). Assembly of the NC occurs
in a stepwise manner starting with embedding protein rings into the bacterial membrane
(Galan & Wolf-Watz, 2006; Chatterjee et al., 2013). The first proteins to build the NC are pi-
lotins and secretins, which are secreted via the sec-pathway across the inner membrane and
are essential building blocks for type III and also type II or type IV secretion systems (Bayan
et al., 2006). The pilotin helps with insertion of the secretin into the outer bacterial mem-
brane which in turn provides a structural basis for attachment of additional protein multimers
(Bayan et al., 2006; Chatterjee et al., 2013). Rings of variable stoichiometry are stacked on
top of each other until the membrane-spanning part is completed. This unit is the basal body
and has an inner diameter of about 30 to 40 nm. In S. flexneri, the basal body consists of
rings of MxiG and MxiJ in the inner and MxiD in the outer membrane, where MxiD is a secretin
that targets the outer membrane with the assistance of the pilotin MxiM (Schuch & Maurelli,
2001). Together, these rings enclose a central tube-like structure, called the inner rod, which
is formed by MxiI (Fig. 1.4).
Once the basal body is complete, the needle is formed by numerous copies of a small
protein with a hairpin structure (MxiH in S. flexneri). The yet unfinished system secretes the
structural needle-protein during assembly of the extracytosolic appendage (Erhardt et al.,
2010). The hollow needle grows at the distal end and usually ranges between 45 and 50 nm
in length, which is regulated by Spa32 in S. flexneri (Tamano et al., 2000, 2002). The inner
diameter of the needle is about 2-3 nm and is considerably smaller than the basal body.
Recently, a channel of 2.5 nm has been confirmed in Salmonella SPI-1 which is conserved in
S. flexneri and thereby seems to be a universal feature of the Inv-MxiG-Spa T3SS (Loquet
et al., 2012; Demers et al., 2013). The assembly of the central channel is assisted by the
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Needle
(MxiH)
Tip complex
(IpaB/IpaD)
OM rings
(MxiD/MxiM)
IM rings
(MxiJ/MxiG)
C-ring
(Spa47/Spa32/MxiA/MxiK/MxiN)
OM
IM
PP
cytoplasm
Rod
(MxiI)
Figure 1.4: Shigella flexneri needle complex scheme and model. Left: Schematic of the T3SS embedded
in the bacterial envelope, denotations for constituent proteins are given in brackets. Right: Model of the S.
flexneri NC in a lateral section with schematic membranes (modified from Hodgkinson et al. (2009)). OM = outer
membrane, PP = periplasm, IM = inner membrane.
cytosolic proteins MxiN and MxiK, as mutants lacking these proteins did not form secretion-
competent needles (Jouihri et al., 2003). These proteins interact with the ATPase (Spa47 in
S. flexneri) which is an essential component of the basal body and is part of a cytoplasmic
ring (C-ring). Through the interaction with cytoplasmic and structural T3SS components,
the C-ring is thought to orchestrate assembly and substrate secretion (Morita-Ishihara et al.,
2006).
1.2.2 The repertoire of T3SS substrates
Compared to the conserved structural part, the repertoire of effectors is highly diverse
as they shape the interaction between bacterium and host (Preston, 2007). Effector proteins
thereby constitute the armory of pathogenic and symbiotic bacteria and they often mimic or
modify host factors (Galan, 2009). Phosphorylation and ubiquitinylation pathways are com-
mon targets for bacterial effectors that covalently modify host factors, including pathways
regulating the actin network and immune response (Dean, 2011). The variety of interactions
underlines the flexibility in bacterial adaptation to widespread ecological niches where effec-
tors serve as an extensive toolbox to support the bacterium in the host environment.
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Despite this variety, most effectors share the pattern of an N-terminus dedicated to secre-
tion of the protein and downstream domains that provide the actual effector activity. Bioin-
formatic studies developed prediction tools for T3SS signal sequences based on amino acid
composition and structure prediction (Arnold et al., 2009; Lower & Schneider, 2009; Samu-
drala et al., 2009; Yang et al., 2010), although the signal itself is not completely characterized
yet. Many effectors require chaperones for their cytoplasmic stability which bind to their N-
terminal region downstream of the signal peptide. For the S. flexneri effector and translocator
IpaB, two chaperone binding domains have been identified (Lunelli et al., 2009; Lokareddy
et al., 2010), the first of which overlaps with the secretion signal (Fig. 1.5). To prevent ag-
gregation or effector activity in the bacterium, IpaB stays bound to the chaperone IpgC in a
partially unfolded conformation. Without IpgC, IpaB is degraded and recombinant expression
of IpaB requires co-expression of IpgC (Menard et al., 1994b; Page et al., 1999; Lunelli et al.,
2009).
IpaB
IpgC IpgC
1 15 45 51 72 580e ector/transloctor domains
S
Figure 1.5: Schematic of the effector and translocator IpaB. IpaB has an N-terminal signal in the first
15-20 amino acids that overlaps with the first chaperone binding domain (IpgC binding site). An additional IpgC
binding site is further downstream and followed by effector domains. Numbers indicate amino acids, S = signal
sequence.
For reaching the host cytoplasm, effectors require the help of translocator proteins. Translo-
cators are thought to mediate contact with the host-cell membrane where they insert to form
a pore and mediate translocation of other effectors (Müller et al., 2008). Therefore, translo-
cators like IpaB and IpaC in S. flexneri are also situated at or recruited to the tip of the needle
forming a complex that is thought to sense and establish contact with the host (Blocker et al.,
1999; West et al., 2005; Espina et al., 2006; Veenendaal et al., 2007) (Fig. 1.4). IpaD assists
translocon formation and interacts with the needle subunit MxiH and IpaB, thereby connect-
ing the two (Johnson et al., 2007; Epler et al., 2012). IpaB is a multifunctional protein and has,
in addition its translocator activity, at least four different eukaryotic targets. First, it activates
Caspase-1 in phagocytes, thereby stimulating an inflammatory response (Hilbi et al., 1998;
Zychlinsky et al., 1994). Second, it has been shown that IpaB can oligomerize to form ion
channels in the endolysosomal membrane. Subsequent leakage of potassium activates the
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IPAF inflammasome and leads to pyroptosis (Senerovic et al., 2012). Third, there is evidence
for IpaB mediating disruption of the Golgi network, possibly by its CD44/cholesterol-binding
activity (Skoudy et al., 2000; Lafont et al., 2002; Mounier et al., 2012). Last but not least, IpaB
can arrest the host cell cycle by interacting with Mad2L2, an activtiy that possibly decelerates
the otherwise rapid epithelial cell turnover (Iwai et al., 2007).
1.2.3 Through the eye of a needle: Effector secretion by T3SS
Since it is energetically costly to express the T3SS and effectors, the T3SS is strictly reg-
ulated at the level of transcription and secretion. T3SS components are only synthesized
at 37 °C and effectors are stored within the cytosol in an inactive state until a host cell is
encountered (Menard et al., 1994a). The tip complex formed by IpaB and IpaD regulates
secretion and in the absence of host cells Shigella leaks minimal amounts of Ipa proteins
into culture supernatants (Parsot et al., 1995). Mutants of either ipaB or ipaD fail to estab-
lish a regulatory tip complex and hypersecrete effectors without induction. The interaction
between IpaB and IpaD is crucial, as deletion of the 3 C-terminal amino acids in IpaB causes
a hypersecretory phenotype (Roehrich et al., 2010). Secretion can be artificially induced in
vitro by addition of Congo Red (Bahrani et al., 1997), although it remains unclear how the
dye acts on the T3SS. When S. flexneri establishes contact with a host cell, effector pools of
IpaB and IpaC are released entirely into the host cell with a half-time of five minutes (Enninga
et al., 2005). Other effectors are not transcribed until IpaB and IpaC are secreted, as they
are regulated by a feedback loop mediated by IpgC. When IpaB and IpaC are secreted, IpgC
is released and can associate with MxiE. IpgC and MxiE together induce transcription of a
second set of effectors, termed late effectors (Parsot, 2009). Timely regulation of effector
expression provides an efficient way to maintain a secretion hierarchy that is adapted to the
pathogens needs.
Besides temporal regulation, hierarchy of effector secretion occurs through substrate
specificity (Ghosh, 2004; Barison et al., 2013). In S. flexneri, Spa32 is involved in the switch
from basal body components to needle subunits, while MxiC regulates the switch to translo-
cator secretion after the needle is completed (Magdalena et al., 2002; Botteaux et al., 2009;
Martinez-Argudo & Blocker, 2010). Furthermore, a recently discovered protein complex in
Salmonella termed sorting platform was proposed to order substrates prior to secretion by
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the T3SS (Lara-Tejero et al., 2011; Osborne & Coombes, 2011). The protein complex, par-
tially cytosolic and partially associated with the T3SS, delivers the effectors to the T3SS NC
by interacting with the effector-associated chaperone. The sorting platform components are
conserved in other T3SS and shown to interact in Shigella (MxiN, MxiK and Spa47 (Jouihri
et al., 2003)), but thus far, function of this complex has only been investigated in Salmonella.
Once an effector reaches the entry port of the NC, effectors are required to unfold in order
to fit the narrow dimensions of the needle. The inner diameter of the needle is 2.5 nm which
only allows secretion of secondary structures or simple structural motifs. As effectors are
shown to be folded prior to secretion (Wilharm et al., 2004b), activity of an unfoldase is re-
quired. This function is mediated by the ATPase which associates with the NC and the sorting
platform (Akeda & Galan, 2005; Lara-Tejero et al., 2011).
The driving mechanism of effector secretion is not fully elucidated. The ATPase, which
localizes close to the entry port of the NC in the bacterial cytoplasm, has been shown to
be essential for secretion and it is possible that it might be fueling the secretion process.
Secretion also depends on a proton motive force (PMF) as the PMF inhibitor CCCP abolished
secretion in Yersinia and Shigella (Wilharm et al., 2004a; Schroeder et al., 2007). A recent
alternate model proposed rotation of the needle involved in effector secretion (Ohgita et al.,
2013). Based on the similarity to the rotating flagellar export apparatus, structural compo-
nents of the NC needle tip in Pseudomonas aeruginosa have been labeled and rotation has
been observed by microscopy. Whether this is a general feature of secretion mechanism is
not clear. However, rotation fits into the context of the needle being a helical structure with
effectors moving in a screw-like manner through the channel (Wilharm et al., 2007).
1.3 Fusion proteins as tools for secretion analysis
Substrate proteins fused to reporter domains are powerful tools for investigations of se-
cretion mechanisms. The substrate, an effector in case of T3SS, is a carrier for the reporter
which serves as a readout for translocation or localization studies (Fig. 1.6A). In Shigella, this
approach has been used to study kinetics of secretion with effectors that were labeled with
small fluorescent dyes or linked to small enzymatic domains (Schesser et al., 1996; Enninga
et al., 2005). Another possibility is to specifically inhibit transport or system assembly by
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fusing domains that clearly exceed the channel dimensions and cannot be unfolded prior to
secretion (Fig. 1.6B). This leads to obstruction of the channel, preventing secretion of other
effectors. Consequently, only effectors that were secreted before the channel was occluded
are found in culture supernatants or the host.
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Figure 1.6: Monitoring secretion with engineered effectors.(A) Schematic of secretion with labeled effec-
tors (blue molecule with star) that can be transported into the host. (B) Schematic of effector impassable for the
T3SS that blocks secretion of other effectors, effector in the supernatant (light green) was transported before the
channel was obstructed. OM = outer membrane, PP = periplasm, IM = inner membrane.
The T3SS with its narrow channel has been the subject of many studies with either re-
porter fusions or blocking fusions for gaining mechanistic insights. Many of these experi-
ments have been carried out in Yersinia where the T3SS was first discovered. The N-terminal
secretion signal was defined by fusion of truncated effectors to β-galactosidase or alkaline
phosphatase (Michiels & Cornelis, 1991) and could be further specified for YopE fusions where
the N-terminal 11 amino acids were sufficient for secretion (Sory & Cornelis, 1994; Schesser
et al., 1996).
Other experiments have attempted to obstruct the channel using murine dihydrofolate
reductase (DHFR) as a fusion partner for effectors. This approach derived from studies in
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eukaryotic cells where a mitochondrial targeting peptide fused to DHFR directed DHFR to
the mitochondrial compartment (Hurt et al., 1984). DHFR folding can be stabilized by its
ligand methotrexate, making it impassable for translocation and thereby occluding the mi-
tochondrial import channel (Eilers & Schatz, 1986). In Yersinia, DHFR was fused to YopE and
the fusion protein was secreted very little already in the absence of methotrexate (Lee &
Schneewind, 2002). Additional studies revealed that effector fusions including the signal se-
quence and the chaperone binding domain were secreted depending on the presence of the
cognate chaperone SycE (Feldman et al., 2002). In line with these findings was the secretion
of a truncated and thereby destabilized DHFR mutant. Therefore, the chaperone mediates
unfolding of domains downstream of its binding site in the effector. It is noteworthy that
DHFR has been shown to be folded in these fusions prior to secretion (Wilharm et al., 2004b).
This suggests that further active unfolding by the T3SS required, a task probably seen to by
the ATPase and that fusion proteins are indeed unfolded by the T3SS (Wilharm et al., 2007).
In agreement with the ATPase being the potential unfolding component was another study
with Yersinia effectors fused to gluthatione-(S)-transferase. Upon blocking the T3SS, the AT-
Pase was detected in effector fusion-pulldown assays (Riordan et al., 2008). In summary, the
T3SS has complex unfolding capacities that at least partially depend on the ATPase.
1.4 Knotted proteins - Non-linear folds as common motifs
Our general understanding of protein folding is that a linear peptide chain folds into in-
tricate structures, but, like knit-wear, can be unraveled if we pull on both termini. This un-
derstanding has been challenged by the observation of proteins that do not comply with this
model and have a knot as a structural motif. A knot is practically defined as a crossing of
threads which remain folded when a pull is applied to both ends (Virnau et al., 2011). In
particular, knots are technically defined only in closed circles where there is no option for
the ends to slip and untie the knot. Therefore, algorithms for knot identification include arti-
ficial joining of the protein termini, a process that resembles the circle being closed as if we
pick up a string (Taylor, 2000; Yeates et al., 2007). Despite the tendency of long collapsed
chains to form knots, the knotted fold in a protein seemed unlikely at first, as a computa-
tional analysis of the entire protein data bank (PDB, 400 proteins at the time of the analysis)
did not reveal any knots (Mansfield, 1994). This result was challenged by structural data of
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an S-adenosyl methionine-synthetase that obviously contained a knotted motif (Takusagawa
& Kamitori, 1996). An improved analysis of the PDB revealed more than 10 different knot-
ted proteins and already distinguished between simple trefoil knots and more sophisticated
figure-of-eight knots (Taylor, 2000). By now, knotted topologies in proteins are accepted as
common structural motifs and have opened new possibilities for studying protein folding dy-
namics. Although the purpose of knotted folds is not clear, the fact that methyltransferases
with trefoil knots have been found predominantly in extremophiles indicates that knots might
confer additional structural stability (Taylor, 2007).
One example of a knotted methyltransferase is RrmA from Thermus thermophilus, a ther-
mophilic eubacterium. RrmA has a trefoil-knot in the active site and the position of the knot
implies that it is of a deeply-folded nature, meaning that it is unlikely to slide off the chain (Vir-
nau et al., 2011; Nureki et al., 2002). RrmA was the first protein where a deeply-folded trefoil
knot was discovered. Homologs of RrmA are YibK from Haemophilus influenza and YbeA from
Escherichia coli, which, together with RrmA and other methyltransferases containing knots,
have been assigned to the α/β-superfamily of knotted proteins in the Pfam protein database
(Bateman et al., 2004; Mallam & Jackson, 2007b). These proteins usually form homodimers
and bind S-adenosyl methionine as a ligand in their active center. Folding studies revealed
that the knotted motif can refold in vitro without need for chaperones and it was suggested
that the folding process takes place when the chain is largely unfolded (Mallam & Jackson,
2007a). Fusion experiments with these proteins showed that knots still form when either one
or both termini are fused to ThiS from Archeoglobus fulgidus (Mallam et al., 2008). These
findings underlined the intricate folding properties of knotted proteins and suggested that
the knot is formed when the protein is in a largely denatured state.
1.5 Injection revisited:
Does the syringe function as a syringe?
With its defined role as a device that mediates bacterial virulence, T3SS have been the
subject of extensive research in the past 25 years. Early studies with fusion proteins clearly
elucidated a correlation between the fold of a domain and its ability to be secreted. Further-
more, effector proteins from Yersinia were only active when injected into the respective host
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cell in vitro. These findings led to the common hypothesis that effectors are injected into the
host by the bacterium. The discovery of the NC further substantiated this idea. NCs were
isolated from bacterial membranes and were shown to be essential for effector secretion. In
addition, a central channel across the NC was discovered by electron microscopy averaging.
The channel discovery lead to the common belief that effector proteins are delivered by the
means of the NC into the bacterium in a single step, however, this hypothesis has not been
confirmed experimentally.
Regarding studies using effector fusions, it is still possible that these fusions constantly
occupy the ATPase which hampers secretion, leading to an absence of secreted effectors
interpreted as channel obstruction. Thus, these experiments do not prove secretion through
the channel. Opposing the injection model, a recent study in Yersinia demonstrated the
presence of effector proteins which are stored on the outer membrane of the bacterium
and are found in the host cell in later stages of the infection (Akopyan et al., 2011)(Fig.
1.7). These findings contradict the model of single-step translocation from one cytoplasm
to the other, although effector assembly on the bacterial surface was shown to be a T3SS-
dependent process. Even if this study did not exclude the idea of secretion through the NC
channel, it raised questions concerning the purpose of the syringe. An alternative model
considers the syringe as an anchoring device that mediates intimate contact between the
bacterium and the host. Importantly, the authors pointed out that there is no experimental
evidence of effectors being secreted through the NC channel (Edgren et al., 2012).
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Figure 1.7: Model of protein translocation in distinct steps. Bacterial translocators and effectors are
stored on the bacterial cell wall and released only upon host cell contact (1). Translocators (green) form a pore
in the host cell membrane where effectors (blue) are secreted into the target cell (2). OM = outer membrane, PP
= periplasm, IM = inner membrane. Adapted from Edgren et al. (2012).
1.6 Aim of the study
The aim of the study was to answer the question whether or not effector proteins are
secreted through the T3SS channel. Secretion through the NC has two major consequences:
First, effectors need to be unfolded in order to be secreted, as bulky domains are impassable
for the narrow channel. Second, the NC channel shields the substrate from the environment
as it physically surrounds the effector. We proposed that if an effector protein were fused to a
stably folded knotted motif, it could not be unfolded by the T3SS during secretion. The trefoil
knot-motif is a good candidate for blocking the T3SS because first, its size does not fit the re-
stricted dimensions of the channel and second, it stably folds in the absence of chaperones.
The knotted protein was fused to the effector IpaB, which is one of the first effectors being
secreted by the bacterium. IpaB is well characterized and protocols for protein purification
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and testing functionality are available, which would enable us to study the fusion protein
outside the bacterium.
If the fusion protein were trapped in the NC, it would prevent passage of other native
effector proteins. This approach also provides the opportunity to analyze the occupied NC
in more detail and localize the effector protein in an isolated NC. Furthermore, combination
of biochemical assays, like protease treatment and chemical modification, might elucidate
whether the effector fusion protein was accessible or trapped within the NC. While the pro-
tease should not be able to reach the cleavage site if buried inside the channel, the chemical
modification indicates which sites of the protein are still accessible on isolated NCs. Taken
together, this work aims to experimentally address the secretion mechanism in T3SS. This
approach might serve as a convenient tool to study secretion mechanisms of other systems
which require unfolding of their substrates.
2 Results
2.1 Knotted proteins - candidates for blocking T3 secretion
Selection of proteins containing knots as candidates for effector fusions was based on pro-
tein size and structural data available. Both proteins were smaller than 30 kDa and contained
a simple trefoil-knot in the C-terminal region (Fig. 2.1). One protein (Knot 1, Fig. 2.1A) is a
hypothetical protein from the archaeal bacterium Methanobacterium thermoautotrophicum
(PDB 1K3R) (Zarembinski et al., 2003), the other (Knot 2, 2.1B and C, Fig. 2.2) a methyl trans-
ferase RrmA from the eubacterium Thermus thermophilus (PDB 1IPA) (Nureki et al., 2002).
The topology plot shows the trefoil-knot motif highlighted in green, which results from three
peptide crossings in the C-terminal region of RrmA (Fig. 2.2).
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Figure 2.1: 3D structures of the knotted proteins. Full length structural data of Knot 1 (A) and Knot 2 (B)
with the trefoil-knot domains highlighted in green. A close-up of the knotted region in B is given in C.
As the knot locates in the C-terminal part of each protein, it was assumed that knot fold-
ing should be autonomous from an N-terminal fusion to the effector IpaB. Thus, both proteins
appeared to be suitable candidates for stably-folded domains that might obstruct the T3SS
channel.
The influence on effector secretion by these proteins was tested by expressing both knot
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Figure 2.2: Topology of Knot 2/RrmA. Topology plot of Knot 2/RrmA, adapted from Nureki et al. (2002). The
trefoil knot is highlighted in green analog to figure 2.1B and C.
protein-encoding genes without a fusion in the ∆ipaB strain and comparing secretion of in-
duced and non-induced cultures before and after induction.
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Figure 2.3: Secretion assay of ∆ipaB with Knot 1 and Knot 2. Bacterial supernatants were analyzed
by Coomasssie stain before (1) and after (2) induction time points (TP). Cells were left untreated (-) or protein
expression was induced with AHT (AHT). Knot 1 is shown in (A), Knot 2 in (B).
Aliquots of culture supernatants that contain secreted proteins were precipitated with TCA
and analyzed by SDS PAGE and Coomassie stain. A typical effector pattern for hypersecretory
strains was seen for the ipaB mutant as effector proteins accumulated in the supernatants
during the logarithmic growth phase of the culture (Fig. 2.3, lanes TP 1). The protein level
was increased as bacteria were allowed to secrete an additional hour (Fig. 2.3, lanes TP 2)
without induction of expression of the knots. Expression of knot1 influenced the T3SS path-
way as the amount of secreted effectors was decreased after induction (Fig. 2.3A, AHT, TP
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2). This decrease was not observed for the other Knot from T. thermophilus (Fig. 2.3B, AHT).
The protein from M. thermoautotrophicum was therefore excluded from further experiments.
Knot 2 was chosen as a fusion partner for IpaB and is henceforth termed "Knot" (or knot,
for genes). The Knot was fused to the C-terminus of IpaB, resulting in the fusion protein
IpaB-Knot.
2.2 Purified IpaB-Knot induces pyroptosis in macrophages
As an initial step for characterizing the fusion protein, the functionality of IpaB fused to
Knot was tested using purified protein. Expression of ipaB is toxic to E. coli BL21 and toxic-
ity can be circumvented by co-expression of the cognate chaperone ipgC (Lokareddy et al.,
2010). IpgC stabilizes IpaB in the cytoplasm and thereby prevents IpaB degradation (Menard
et al., 1994b). Therefore, IpaB-Knot was co-purified after expressing it together with ipgC
in E. coli BL21. The purification strategy for IpaB is based on purifying the IpgC/IpaB com-
plex via a His-tag in IpgC and subsequent destabilization of the interaction with LDAO. This
destabilization lead to elution of monomeric IpaB (Birket et al., 2007; Senerovic et al., 2012).
Additional affinity purification using Strep-Tactin resin prior to gelfiltration of the protein re-
sulted in the purification of only full-length IpaB-Knot (Fig. 2.4A), as the Strep-tag of the
fusion is C-terminal. Gelfiltration separated aggregated protein from monomeric IpaB-Knot
(Fig. 2.4B).
To ensure that IpaB-Knot remains a functional T3SS effector, IpaBs capability to induce
pyroptosis in murine bone marrow macrophages (mBMM) was analyzed using purified IpaB-
Knot. IpaB is a multifunctional effector and translocator and the induction of pyroptosis is
well documented (Zychlinsky et al., 1994; Senerovic et al., 2012; Lunelli et al., 2009) and
can be assessed with a colorimetric assay. Upon macrophage disintegrity, lactate dehydro-
genase (LDH) is released into the supernatant. Activity of LDH is quantified in a colorimetric
reaction, where LDH reduces a yellow tetrazolium salt (2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-
phenyl-2H-tetrazolium chloride) into a red formazan product. The accumulation of red dye is
proportional to the amount of cells lysed and was quantified in a 96-well plate spectrometer.
IpaB exerts cytotoxicity at concentrations as low as 0.4 µM (Senerovic et al., 2012) and a
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Figure 2.4: Size-exclusion chromatography and analytical SDS PAGE/Coomassie of recombinant
IpaB-Knot. (A) Elution profile of IpaB-Knot. 1, 2 and 3 indicate fractions collected which were analyzed in
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Figure 2.5: Induction of cell death in macrophages by IpaB-Knot. Cell death was measured by release of
LDH from mBMM in a colorimetric assay. Error bars indicate SD, n=3 independent experiments.
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similar result was obtained for IpaB-Knot, where cytotoxicity was already seen at 0.25 µg/ml
(0.26 µM) (Fig. 2.5). At 0.5 µg/ml (0.53 µM), cell lysis was as efficient as disruption with 1 %
detergent (Triton X-100). Since IpaB-Knot is concentrated in the presence of LDAO, the de-
tergent might accumulate during protein concentration and enhance cytotoxicity. To rule out
a cytotoxic effect of LDAO, the non-toxic protein bovine serum albumin (BSA, 66 kDa) was
concentrated under same conditions as IpaB-Knot and added to mBMM. No cellular disinte-
gration was detected in samples with 50 µg/ml (0.75 µM) BSA. Thus, disruption was caused by
a functional IpaB domain in IpaB-Knot. This confirmed that IpaB maintains effector function
inside the fusion protein.
2.3 The Knot is folded within IpaB-Knot
For efficient obstruction of the NC channel by IpaB-Knot, the Knot has to be tightly folded
when fused to IpaB. Since IpaB is stored in complex with IpgC in the bacterial cytoplasm, the
complex of IpaB-Knot and IpgC represents the conformation of IpaB-Knot prior to secretion.
As the Knot needs to fold prior to secretion, folding analysis was carried out on IpaB-Knot
bound to IpgC by means of fluorescence spectrometry and limited proteolysis.
2.3.1 Fluorescence spectrometry
Fluorescence spectrometry measures the intrinsic fluorescence of the protein which largely
depends on tryptophan residues and their molecular environment. Thereby, different folding
states of the protein can be compared as the emission spectrum changes when tryptophans
are exposed to solvent upon unfolding. The folding status of the Knot-domain in IpaB-Knot
was addressed by measuring the change in tryptophan fluorescence under native and dena-
turing conditions (Fig. 2.6). IpaB contains a single tryptophan whereas the Knot domain has
four tryptophans, three of which are part of the trefoil knot in the C-terminal region, indicat-
ing that the fluorescence is mainly derived from folding status of the Knot. Fluorescence of
IpaB-Knot in complex with the chaperone IpgC was recorded. IpgC does not contain trypto-
phans and was included in the blank buffer as a control.
Spectra of purified IpaB-Knot complex were compared to spectra of the Knot alone, either
in buffer or in the presence of the chaotropic salt guanidine hydrochloride (GuHCl). The native
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Figure 2.6: Fluorescence spectra of IpaB-Knot and Knot. Solid lines represent native conditions, dashed
lines show spectra under the influence of 6 M guanidine hydrochloride.
Knot protein had a fluorescence emission peak at 335 nm which represents tryptophans in the
folded protein (Fig. 2.6, solid grey line). The fluorescence spectrum of IpaB-Knot was similar
to the native Knot spectrum with an emission peak at 335 nm (Fig. 2.6, solid black line).
This similarity of fluorescence spectra suggests folding of Knot in IpaB-Knot analog to native
Knot. Treatment with 6 M GuHCl lead to unfolding represented by a red shift of emission
peaks from 335 nm to 355 nm. This shift indicated a change of the molecular environment
due to exposure of the respective tryptophans to solvents in both IpaB-Knot and Knot alone.
Thus, the change in fluorescence derived from GuHCl-induced structural alterations of the
Knot domain confirms that this domain was folded under the tested conditions.
2.3.2 Protease treatment reveals a folded core including the trefoil knot
Folding of a protein can be analyzed in more detail with treatment by unspecific pro-
teases. Under native conditions, the protein fold prevents cleavage by proteases. Only free
structures can be accessed by the enzyme and the folded parts remain intact over time.
For the Knot protein alone, protein fragments were obtained by treatment with the non-
specific protease Proteinase K and separated by SDS PAGE (Fig. 2.7A).
Already after a few minutes of incubation, treatment led to a product of approximately
25 kDa which is no further digested. The cleavage product was stable because of its native
fold, as total cleavage of Knot occurred in the presence of the denaturing detergent SDS, a
condition where Proteinase K is active (Hilz et al., 1975). The obtained fragment was ana-
lyzed by mass spectrometry (MS) (Fig. 2.7B) and mapped on the known structure for RrmA
(Fig. 2.7C). Only the terminal helices were cleaved whereas the trefoil knot remained intact.
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Figure 2.7: Protease K treatment of Knot under native and denaturing conditions. (A) SDS PAGE
and Coomassie stain of Knot treated with Proteinase K (PK) or untreated (-) under native (-SDS) and denaturing
(+SDS) conditions, where Proteinase K is still active. (B) 3D structure of Knot mapped with fragment identified
by MS from the stable band in (A). The trefoil knot is indicated by a green box. (C) MS spectrum of the stable
fragment. Peptides are indicated on peaks, see Fig. 2.10 for Knot sequence. MS analysis was performed by
Monika Schmid, MPIIB.
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Like treatment of Knot, IpaB-Knot (in complex with IpgC) was digested with Proteinase K and
the sample was analyzed by 2D-electrophoresis in order to obtain a better resolution of IpaB
fragments and the Knot (Fig. 2.8). Protein spots that appeared after digest were further an-
alyzed by MS and MS/MS. Some peptides resulted from digestion of the IpaB domain, which,
in complex with IpgC, was partially unfolded when treated with Proteinase K (Fig. 2.8, Box 1).
As seen for the Knot, polypeptides that cover almost the entire sequence of the Knot domain
and the complete sequence of the trefoil-knot motif were detected (Fig. 2.8, Box 2).
1
2
- Proteinase K + Proteinase K
MW
IEF
Figure 2.8: 2D-electrophoresis of IpaB-Knot. IpaB-Knot was separated by isoelectric focus (IEF) and molec-
ular weight (MW) as a second dimension without Proteinase K (left) or after Proteinase K treatment. Protein
fragments after Proteinase K digest were analyzed by mass spectrometry. Electrophoresis was performed by
Ursula Zimny-Arndt, MPIIB.
Subfragments from these spots were confirmed by MS/MS analysis (Fig. 2.9). y and b ions
have been mapped to fragments with the respective charge retained either at the N-terminus
(b) or C-terminus (y). Although the spectrum for the IKELAR-peptide was of low quality (Fig.
2.9A), the FLIEGAR peptide matched the N-terminal peptide of the Knot in IpaB-Knot (Fig.
2.9B) and the LLRDL peptide confirmed the C-terminal fragment (Fig. 2.9C). Again, only
the C-terminal helix and N-terminal parts of the Knot domain, but not the trefoil knot, were
cleaved, suggesting that this motif is folded and consequently inaccessible to Proteinase K
(Fig. 2.10).
Fluorescence analysis and mass spectrometry after limited proteolysis substantiate a
folded core domain of Knot in IpaB-Knot. This includes the trefoil-knot motif which was un-
folded by GuHCl and resistant to proteolysis by Proteinase K under native conditions.
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Figure 2.9: MS/MS analysis of IpaB-Knot. Spectra for N-terminal and C-terminal fragments of Knot after
Proteinase K digest of IpaB-Knot and separation of peptides by 2D gel electrophoresis (analysis of Box 2 from Fig.
2.8). b and y anions correspond to amino acids with charge retained on the N-terminus (y) or C-terminus (b).
Analysis was performed by Monika Schmid, MPIIB.
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------------------------------------------MRITSTANPRIKELARLL
ERKHRDSQRRFLIEGAREIERALQAGIELEQALVWEGGLNPEEQQVYAALGRVGRLALLE
VSEAVLKKLSVRDNPAGLIALARMPERTLEEYRPSPDALILVAVGLEKPGNLGAVLRSAD
AAGAEAVLVAGGVDLYSPQVIRNSTGVVFSLRTLAASESEVLDWIKQHNLPLVATTPHAE
ALYWEANLRPPVAIAVGPEHEGLRAAWLEAAQTQVRIPMQGQADSLNVSVSAALLLYEAL
RQRLLRDRLTKTHSTLSAWSHPQFEK
Strep-tag
linkerIpaB Knot
trefoil knot-motif
...
Figure 2.10: MS and MS/MS analysis of IpaB-Knot. Identified peptides by MS are highlighted in red in the
Knot sequence and fragments confirmed by MS/MS are highlighted bold. The Knot is indicated by a green line
above the amino acid sequence.
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2.4 Plasmid-encoded IpaB-Knot: effects on hypersecretion
The fusion protein was introduced into hypersecretory strains, the ∆ipaB or ∆ipaD strain
in order to analyze effects on T3SS. In the initial approach, fusion genes were expressed from
inducible plasmids with a tetracycline-promoter after bacteria had grown into the logarithmic
phase.
2.4.1 Induced expression in ∆ipaB
The ∆ipaB strain was complemented with plasmids containing either pipaB or pipaBknot
and secretion was analyzed by SDS PAGE and silver stain (Fig. 2.11). Induced cultures were
washed and splitted and leaky secretion (-CR) was differentiated from Congo Red-induced
secretion (+CR) (Fig. 2.11A). Effector secretion in the ∆ipaB strain is not affected by Congo
Red-addition except for one band missing at 40 kDa. In comparison, expression of pipaB
leads to absence of a doublet at 60 kDa and a band at 38 kDa. Secretion could be enhanced
by Congo Red, as additional bands appeared (e.g. 50 kDa, 52 kDa, 60 kDa and 70 kDa). For
complementing ∆ipaB with pipaBknot, no secretion was observed after adding Congo Red.
Secretion was analyzed in more detail by Western blotting. For the ∆ipaB + pipaB strain,
IpaB was detected in supernatants after gene expression of pipaB was induced. In this strain,
secretion was enhanced in the presence of Congo Red (Fig. 2.11B). This was not observed
for ∆ipaB complemented with pipaBknot, although intracellular protein levels were equal
for both IpaB and IpaB-Knot (Fig. 2.11C). The intracellular chaperone DnaK in supernatants
served as a marker for cellular disintegrity. DnaK was not detected in the supernatants which
confirms bacterial viability in this experiment. Furthermore, IpaB-Knot was not secreted in
this strain and also influenced secretion of other effectors when expressed from a plasmid.
2.4.2 Induced expression in ∆ipaD
Since the aim was to block the T3SS channel with the fusion, expressing the fusion in the
background of a strain that secretes the effector IpaB in the absence of Congo Red induction
was considered. The∆ipaD strain has a hypersecreting phenotype similar to∆ipaB, secretes
IpaB as well as other effectors without Congo Red (Menard et al., 1994a) and IpaB does not
contribute to regulation of secretion in∆ipaD. Unlike in the∆ipaB strain, expression of pipaB
or pipaBknot should not restore wildtype secretion, thus no Congo Red-induction is needed.
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Figure 2.11: Secretion assay of ∆ipaB with IpaB-Knot. (A) Bacterial supernatants were analyzed by silver
stain after induction with AHT or without induction (∆ipaB / -). Induced samples were further grown in the
presence of Congo Red (CR+) or without Congo Red (CR-). (B) Supernatants analyzed by Western blotting with
IpaB and DnaK mouse monoclonal antibodies. One lysate was included as an DnaK antibody control (ctrl). (C)
Bacterial lysates analyzed by Western blotting with IpaB mouse monoclonal antibody.
Expression of either pipaB or pipaBknot in ∆ipaD was investigated in comparison to an
mxiH mutant (secretion deficient) and the untransformed∆ipaD strain. These strains served
as controls to monitor effects of AHT (+) or DMF (-, vehicle), as secretion was analyzed
from overnight-grown cultures in order to accumulate more effector proteins in culture su-
pernatants (Fig. 2.12A).
For induced expression of pipaB, analysis of SDS PAGE and Coomassie stain showed a
slight reduction in secretion compared to the ∆ipaD control but the typical pattern of se-
creted effector proteins was retained (Fig. 2.12A, middle panel). With regards to the effector
proteins secreted, the ∆ipaD strain with induced pipaBknot was completely deficient in se-
cretion and only residual proteins were detected in the supernatant (Fig. 2.12A, right panel).
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Figure 2.12: Secretion assay of ∆ipaD with IpaB or IpaB-Knot. (A) Coomassie stain of precipitated
culture supernatants of ∆mxiH, ∆ipaD and ∆ipaD plus plasmid-encoded pipaB or pipaBknot. All strains tested
were treated with DMF (-) or AHT in DMF (+). Supernatants were normalized. (B) Western blot analysis of strains
from A, probed with anti-IpaB mouse mAB, anti-IpaC rabbit pAB, anti-MxiG mouse mAB, piB: plasmid-ipaB, piBk:
plasmid-ipaBknot, IB: IpaB, IBK: IpaBKnot.
The effect on secretion by pipaBknot and lack of effector synthesis due to regulatory ef-
fects were further differentiated. Western blot analysis of IpaB in supernatants and lysates
showed that the ∆ipaD strain secreted IpaB whereas the ∆mxiH did not and both strains
had equal levels of IpaB in the cytoplasm (Fig. 2.12B, supernatants and lysates, upper left
panels). The level of IpaB in ∆ipaD represents the basal intracellular amount of IpaB for this
bacterial background. This level, as well as the amount of secreted IpaB, was increased by
additional expression of pipaB (supernatants and lysates, middle panels). In ∆ipaD express-
ing pipaBknot, the amount of secreted IpaB as well as the intracellular level of endogenous
IpaB were reduced and cytoplasmic levels of IpaB-Knot (IBK) were comparable to IpaB (IB)
in ∆ipaD. Again, IpaB-Knot was not secreted. IpaC was analyzed as an additional effector
protein. Levels of IpaC in supernatants and cytoplasm were reduced compared to ∆ipaD +
pipaB. This only applied to effector proteins, as levels of MxiG, a structural component of the
NC basal body, were not altered in bacterial lysates.
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2.5 Insertion of knot into pWR100
Expression of pipaB-knot influenced the cytoplasmic level of effectors, including IpaB,
which is due to the regulatory function of IpaB. Therefore, the strategy for ipaBknot expres-
sion in the bacterium was changed and ipaBknot was expressed under the native promoter
of ipaB. The gene encoding ipaB was fused to the knot gene by insertion of the coding se-
quence into the virulence plasmid in S. flexneri, together with the codons for a strep-tag (Fig.
2.13A). The gene was placed 3’ in the ipaB open reading frame, resulting in ipaBknot, which
was then expressed under the control of the native promoter in the ipgCipaBCDA operon.
The insertion was verified by colonyPCR with oligonucleotides (half arrows in Fig. 2.13A) that
annealed up- and downstream of the insertion site. In the wildtype, the PCR product was
about 300 bp, whereas insertion of knot together with the chloramphenicol cassette (cam)
resulted in a product of about 2 kb (Fig. 2.13B).
ipaB ipaCipgC
knot cam
ipgC knotipaB cam ipaC
pWR100 (M90T or ΔipaD)
:: ipaBknot
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Figure 2.13: knot insertion in the virulence plasmid pWR100. (A) Schematic of homologous recom-
bination mediated by Flp recombinase. (B) Agarose-gel of PCR products from genotyping of M90T (wt) or
M90T::ipaBknot (1-3).
IpaB was thereby replaced by IpaB-Knot (with a C-terminal Strep-tag, 93 kDa). This strat-
egy was applied to both M90T wildtype and the hypersecretor ∆ipaD.
2.6 IpaB-Knot does not complement IpaB in invasion
IpaB plays an essential role during bacterial invasion of epithelial cells (Menard et al.,
1993), and since it was shown before that IpaB is functional in fusion with Knot, effects on
invasion caused by the fusion protein were analyzed.
Invasiveness was quantified in a gentamicin protection assay (Sansonetti et al., 1982) by
Chapter 2. Results 38
comparing invasion of M90T::ipaBknot to wildtype M90T and the ∆ipaB mutant (Fig. 2.14).
M90T::ipaBknot showed a 1000-fold decreased invasion phenotype comparable to the nega-
tive control ∆ipaB (Fig. 2.14A).
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Figure 2.14: Invasion assay with S. flexneri strains and Western blot analysis. (A) Invasiveness quan-
tified by colony-forming units (CFU) per ml culture. Two clones were grouped, each as a technical triplicate, and
compared by multiple t-test. (B) Western blot analysis of IpaB, MxiG and DnaK (loading control) in whole cell
lysates.
The observed deficiency in invasion was not based on altered expression of ipaBknot
when protein levels were compared to wildtype IpaB in M90T (Fig 2.14B). A deficit in express-
ing structural components of the NC was excluded by Western blot, which revealed equal
levels of MxiG in all three strains. As previous results demonstrated a functional IpaB do-
main in IpaB-Knot, it is likely that the phenotype of decreased invasion is based on IpaB-Knot
affecting the T3SS pathway.
2.7 IpaB-Knot influences regulation of effector secretion
Since bacteria expressing ipaBknot are not invasive despite normal expression of func-
tional IpaB-Knot and T3SS components, effects on secretion were investigated. Secretion of
bacteria that carry the fusion allele ipaBknot was analyzed in comparison to wildtype M90T
(with or without Congo Red induction), the hypersecretory mutant∆ipaB as a positive control
and ∆mxiH as a negative control (Fig. 2.15). The Coomassie stain in Fig. 2.15 shows effector
proteins from culture supernatants that were secreted by the indicated bacterial strain.
Compared to M90T and the ipaB-deficient strain, M90T::ipaBrrmA phenocopied both strains.
Secretion comparable to ∆ipaB was observed already without induction of Congo Red. With
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Figure 2.15: Coomassie stain of effector proteins (secretion assay). Amounts were normalized to culture
density. Induction with Congo Red is indicated by +, or - for no induction, respectively.
induction, the number of proteins in the supernatant increased by an additional band visible
at about 55 kDa and the pattern resembled M90T under the influence of Congo Red. This
suggests that secretion is deregulated when IpaB is replaced by IpaB-Knot in M90T.
2.8 IpaB-Knot impedes T3SS secretion
2.8.1 The effect of IpaB-Knot on effector secretion
For further analysis of effects on the T3SS pathway and better comparison of secretion
phenotypes, an ipaD-deficient strain (∆ipaD) was used as a background for the expres-
sion of genomic ipaBknot. Secretion of ∆ipaD (∆), ∆ipaD::ipaBknot (∆+) strain and of a
secretion-deficient negative control (∆mxiH∆ipaD, ∆∆) were compared in overnight cul-
tures and amounts of secreted proteins were monitored by SDS PAGE and Coomassie stain
(Fig. 2.16A) or Western blotting (Fig.2.16B).
Opposing hypersecretion in ∆ipaD, the amount of proteins secreted by ∆ipaD::ipaBknot
was merely residual. In contrast, SepA, an autotransporter and substrate to a type V secre-
tion system (Henderson et al., 2004), was equally present in all strains (Fig. 2.16A, 110 kDa
and B, upper panel). This lead to the conclusion that only amounts of T3SS-dependent pro-
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Figure 2.16: Secretion assay with S. flexneri strains and Western blot analysis. (A) SDS PAGE and
Coomassie stain of precipitated proteins from either ∆mxiH∆ipaD (∆∆), ∆ipaD (∆) or ∆ipaD::ipaBknot (∆+)
shown for two clones. (B) Western blot analysis from (A) of proteins secreted or bacterial lysates using different
antibodies as indicated.
teins were decreased in supernatants of ∆ipaD::ipaBknot.
The limited secretion in ∆ipaD::ipaBknot was confirmed by more specific Western blot
analysis (Fig. 2.16B). IpaB was found in supernatants of ∆ipaD which contrasts the entirely
cytoplasmic localization of IpaB-Knot in ∆ipaD::ipaBknot. The supernatants and bacterial
lysates from ∆ipaD and ∆ipaD::ipaBknot were tested for the translocator IpaC and the ef-
fector IpaH. The amount of secreted IpaC was reduced in supernatants of ∆ipaD::ipaBknot
but not in ∆ipaD. Furthermore, cytoplasmic levels of IpaC showed equal protein synthesis
which underlines an effect on the secretion pathway but not expression. IpaH belongs to
the second set of effectors (late effectors) which are regulated by the IpgC/MxiE feedback
loop (Schroeder & Hilbi, 2008). Representing one late effector, IpaH was found to be reduced
in the supernatants as well as in bacterial lysates. Hence, the observed reduction of T3SS-
dependent proteins in supernatants resulted from less secretion as well as downregulation
of late effector genes.
Chapter 2. Results 41
2.8.2 Expression of knot has no effect
As a control, the Knot-encoding gene was expressed by insertion into pWR100 together
with the ipaC ribosomal binding site between ipaB and ipaC. As in the previous experiment,
proteins from bacterial supernatants were analyzed by Coomassie-stained SDS PAGE and
Western blotting. The effector pattern observed resembles the secreted proteins of the
∆ipaD mutant strain and did not show deficits in protein secretion (Fig. 2.17, left panel). As
the intracellular levels of IpaC were not reduced in the ∆ipaD::ipaBknot strain, knot mRNA
should be translated under the control of the ipaC ribosomal binding site. Production of Knot
was detected in the bacterial cytoplasm using an anti-Strep tag antibody. The Knot was found
in the cytoplasm only and was not secreted (Fig. 2.17, right panel).
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Figure 2.17: Secretion assay with S. flexneri strains and Western blot analysis. Two clones are shown
with effector proteins secreted (left) and specific Western blot analysis with anti-IpaB, anti-MxiG and anti-Strep
antibody (detection of Knot).
In agreement with the expression of knot from the inducible plasmid system in figure 2.3,
expression of knot without fusion under the native promoter of the ipaB- and ipaC-including
operon did not affect the T3SS pathway. Neither effector synthesis nor bacterial integrity
were influenced, as levels of IpaB and MxiG were equal to ∆ipaD (Fig. 2.17, right panel,
compared to 2.16B). In summary, fusion of IpaB to the Knot but not unfusioned Knot reduced
T3SS-dependent effector secretion and synthesis (late effectors) in the hypersecretor∆ipaD.
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2.9 Needle complexes co-purify with IpaB-Knot
Next, the question emerged if attenuated secretion was the result of IpaB-Knot interacting
with the NC. Interaction of IpaB-Knot and NCs were studied on NC isolates from∆ipaD::ipaBknot
using cesium chloride density fractionation where a continuous salt gradient is built over
time by centrifugal force and large protein complexes are separated from smaller soluble
proteins. Isolated NCs were detected with an anti-MxiG antibody, as MxiG constitutes the
inner membrane ring which is an integral part of the NC (Blocker et al., 2001). Residual IpaB
was separated from the NCs which is in agreement with the observation that IpaB is unable
to bind to the NC in the ∆ipaD mutant (Veenendaal et al., 2007). In contrast to IpaB which
remained in the low-density fraction, NCs migrated to high-density fractions (Fig. 2.18A). This
migration pattern was opposed by isolates from ∆ipaD::ipaBknot where IpaB-Knot migrated
with isolated NCs to high-density fractions (Fig. 2.18B).
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Figure 2.18: Density gradient fractionation of needle complexes and IpaB or IpaB-Knot. Separation
of NC isolates from ∆ipaD (A), ∆ipaD::ipaBknot (B), ∆ipaD plus purified IpaB-Knot (C) or purified IpaB-Knot only
(D). Western blot analysis of fractions (CsCl# 1 to 6) with 1 being the low density fraction. anti-IpaB mAB and
anti-MxiG mAB were used simultaneously.
IpaB-Knot from recombinant expression (rIpaB-Knot) was added to purified NCs from
∆ipaD cells (Fig. 2.18C) to further characterize the nature of potential interaction. Purified
IpaB-Knot remained in low-density fractions and did not migrate with NCs to high-density
fractions, which was also seen for purified IpaB-Knot without isolated NCs (Fig. 2.18D) and
therefore aggregation as a cause for migration to higher densities was excluded. This co-
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migration suggests interaction between the NC and IpaB-Knot in the ∆ipaD::ipaBknot strain
which might result from attempted secretion and subsequent obstruction of the T3SS by
IpaB-Knot.
2.10 Localization of IpaB-Knot at isolated needle complexes
(overall NC population)
Based on previous results, IpaB-Knot was localized at the isolated NCs. Localization of
IpaB-Knot at NCs was investigated after density fractionation using immuno-electron mi-
croscopy (iEM). Fractions that contained both IpaB-Knot and MxiG (Fig. 2.18B, fractions 4
and 5) were further purified by gelfiltration as cesium chloride interfered with visualization
due to its high electron density. After gelfiltration and subsequent concentration of NCs, the
samples were stained on grids with an anti-IpaB monoclonal antibody (mAB), which binds to
an N-terminal epitope between the residues 118 and 179 (Barzu et al., 1993). Using this an-
tibody, the IpaB epitope of IpaB-Knot could be detected either at needle tips or at the basal
side of isolated NCs (Fig. 2.19A-D).
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Figure 2.19: Gold labeling of IpaB-Knot at isolated NC. IpaB was detected with anti-IpaB mAB and goat
anti-mouse, 12 nm gold conjugate. (A) Example iEM image of anti-IpaB labeling in isolated NCs with magnified
details (indicated by arrows in (A)) in (B-D). (E) Distribution of distances between NCs and gold particles in 50
images, including (A).
IpaB was not detected in samples of isolated NCs from the ∆ipaD strain which is consis-
tent with IpaB being separated from NCs in these samples (Fig. 2.18A). To assess whether the
observed co-localization between IpaB-Knot and NC is specific, 50 random iEM images were
quantified and coordinates for gold labeling IpaB and NCs were recorded manually. Average
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counts comprised of 80 NC and 20 labels per image (Fig. 2.19E).
In order to obtain a random distribution of gold and NCs, respective coordinate X and Y
values were randomized according to counts per image within the range of the image di-
mensions. Both counted and simulated coordinates were subjected to a nearest-neighbor
analysis, quantifying distances between NC centers and the closest adjacent gold particles
(Fig 2.20A).
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Figure 2.20: Nearest-neighbor analysis of isolated NCs and gold. IpaB was detected with anti-IpaB mAB
and goat anti-mouse, 12 nm gold conjugate. (A) Coordinates for NC centers (x1) and gold particles (x2) were
manually selected. (B) Distribution of distances between NCs and gold particles in 50 images.
The distribution of counted NC/gold distances shows a maximum around 30 to 50 nm,
whereas distances from a random distribution of according gold and NC numbers per image
peaked around 100 nm to 120 nm (Fig. 2.20B).
2.11 Detection of IpaB-Knot C-terminus in occupied NCs
About 25 % of the NC were positive for gold labeling of the IpaB-Knot N-terminus. Since it
cannot be distinguished if only 25 % interact with IpaB-Knot or if this is a technical limitation,
NCs occupied by IpaB-Knot were specifically enriched. Purified NCs from solubilized mem-
brane fractions were immobilized on sepharose using Strep-Tactin resin which binds to the
C-terminal Strep-tag of IpaB-Knot. NCs eluted from the resin after treatment with desthiobi-
otin, however, some NCs were still bound to the resin (Fig. 2.21A) The purification using resin
lead to the elution of partially damaged NCs, as many NCs were deficient for basal body rings
of the inner membrane (Fig. 2.21B) and consisted merely of the central channel.
The isolated channels were still positive for IpaB-Knot. Regarding the bilateral labeling
seen for IpaB, labeling of the C-terminus of IpaB-Knot occurred mostly at the basal side of
the isolated NC (Fig. 2.22B, C and D) with rare exceptions (Fig. 2.22E). For isolated channels
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with an incomplete base, the basal side was distinguished from the distal side by localizing
the long needle on the distal side of the NC.
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Figure 2.21: Batch purification of NCs using Strep-Tactin resin. (A) Western blot analysis of batch purifi-
cation detecting IpaB-Knot (93 kDa) and MxiG (42 kDa) simultaneously; FT: Flow through, B: beads. (B) TEM of
elution fraction 1 from batch purification.
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Figure 2.22: anti-Strep tag labeling on isolated NCs. (A) Overview of labeled NCs and magnifications
shown in (B-E); scale bars indicate 100 nm.
2.11.1 Production of humanized IpaB mAB
Labeling with different gold-conjugated secondary antibodies enables distinguishing be-
tween epitopes, if different species of primary antibodies are used. Each secondary antibody
is coupled to gold colloids of defined diameters. Since both the IpaB mAB and the Strep-tag
mAB are murine antibodies, the IpaB mAB was expressed as a human IgG1.
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The hybridoma H16 is based on a spleen cell line fused to the IpaB mAB-producing B cell
(Barzu et al., 1993). After obtaining H16 cDNA, the B cell receptor (BCR) genes encoding
the variable regions were amplified, resulting in two overlaying sequences. One represents
the genomic BCR of the spleen cell, the other sequence contains information on the variable
segment of the IpaB-specific BCR. Since the variable region of the spleen BCR is known, the
sequence of the IpaB-specific BCR was extracted from the overlaying signal (by manually
subtracting the spleen BCR signals) and an IpaB-BCR specific primer was chosen for sub-
cloning of the respective variable segment. The plasmids contain human constant regions
of IgG1 heavy and light chains. By insertion of the murine variable region, an IpaB-specific
human monoclonal antibody (hmAB) was generated.
Purified IpaB hmAB was tested for specificity by Western blot analysis (Fig. 2.23). Bacte-
rial lysates of ∆ipaD::ipaBknot were probed for IpaB-Knot with combinations of either IpaB
mAB and goat-anti mouse horse-radish peroxidase (HRP), IpaB hmAB and goat-anti mouse
HRP, IpaB mAB and goat-anti human HRP or IpaB hmAB and goat-anti mouse HRP. Signals
were obtained only for matches of primary antibodies with species-specific secondary anti-
bodies (Fig. 2.23A and C). This demonstrated suitability of the IpaB hmAB for concomitant de-
tection of the IpaB-epitope and the Strep-tag by the Strep-tag mouse mAB, as non-matching
secondary antibodies did not evoke unspecific signals.
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Figure 2.23: Western blot analysis of mouse and human anti-IpaB. Primary (1) and secondary (2) anti-
bodies were combined as indicated.
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2.11.2 Simultaneous detection of IpaB-Knot N- & C-terminus
Labeling both the IpaB epitope and the Strep-tag on enriched occupied NCs was per-
formed with the IpaB hmAB and the Strep-tag mAB simultaneously. In a few cases, NCs were
labeled on both sides with the IpaB epitope detected at the tip and the Strep-tag epitope at
the base (Fig. 2.24). Compared to single labeling, this was a rare event compared to single
labeling, but was reproducable when both antibodies were used. Also multiple gold parti-
cles for each epitope were detected (Fig. 2.24B-D). Importantly, only labeling of one epitope
occurred if one primary antibody was used together with both secondary gold-conjugated
antibodies.
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Figure 2.24: Double labeling of IpaB N-terminus and C-terminal Strep-tag on isolated NCs. (A)
Overview image with two double labeled NCs. (B-D) Magnified double-labeled NCs chosen from different im-
ages; scale bars indicate 100 nm.
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2.12 The T3SS channel shields parts of IpaB-Knot
It was examined whether IpaB-Knot was inserted into the NC channel by testing the ac-
cessibility of the fusion protein. According to a conduit model for T3SS where effectors are
secreted through the NC, part of IpaB-Knot should be enclosed by the NC channel. After ob-
struction, the effector should remain inside the needle and would be shielded from enzymatic
modifications or crosslinking chemicals that cannot penetrate into the channel.
2.12.1 The fusion protein is inaccessible to TEV protease
The IpaB-Knot fusion was modified with a TEV protease-specific cleavage site between
both domains of IpaB-Knot. ∆ipaD::ipaBTEVknot NC isolates occupied with IpaB-TEV-Knot
and IpaB-TEV-Knot purified from E. coli BL21 were coupled to Strep-Tactin sepharose beads
via the Strep-tag and subsequently treated with TEV protease.
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Figure 2.25: TEV protease treatment of isolated NCs and purified IpaB-TEV-Knot. Isolated NCs are
shown in the upper panel and purified protein in the lower panel. Western blot analysis was performed with
anti-IpaB mAB and anti-MxiG mAB simultaneously.
Supernatants with enriched cleavage products and bead fractions were analyzed by West-
ern blotting after protease treatment. IpaB-TEV-Knot co-purified with NCs showed almost no
cleavage products (IpaB’) after treatment with increasing concentrations of TEV protease
(Fig. 2.25, upper panel). In comparison, control IpaB-TEV-Knot purified from E. coli was en-
tirely cleaved by TEV protease (Fig. 2.25, lower panel). Purified IpaB-TEV-Knot decreased
in direct correlation with released IpaB’ accumulating in supernatants. Cleavage efficiency
depended on the amount of TEV protease, however, already at low concentrations, almost
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all IpaB-TEV-Knot was digested. Some IpaB’ was seen in the bead fractions, which could be
due to a non-specific interaction. The cleavage pattern indicates that IpaB-TEV-Knot puri-
fied with NCs is protected from enzymatic cleavage and digestion of purified IpaB-TEV-Knot
demonstrates an accessible TEV recognition site for the fusion protein in the absence of NCs.
2.12.2 Chemical modification is limited by the presence of the NC
To gain better insights into the protective effect by the NC, the extent to which IpaB-Knot
can be modified by treatment with crosslinking polyethylene glycol molecules (PEGylation)
was assessed. Each PEG increases the molecular weight by 1.1 kDa and has a defined arm
length of 8.8 nm. Consequently, PEGylation molecules cannot penetrate or diffuse into the
NC channel for sterical reasons. Proteins can be PEGylated by crosslinking of primary amines
(lysine residues and protein N-terminus) to the NHS-group of PEG. In IpaB-Knot, 58 PEGylation
sites are evenly distributed across the protein. Analog to the TEV protease assay, Strep-Tactin
beads were saturated with either purified IpaB-Knot or isolated NCs containing IpaB-Knot.
The beads were treated with PEGylation agent and subsequently analyzed using a Strep-tag
antibody. The Step-tag at the C-terminus of IpaB-Knot has no PEGylation sites and therefore
the antibody epitope should not be modified. PEGylated IpaB-Knot shifted to about 110 kDa
compared to 93 kDa for unmodified protein, which corresponds to PEGylation at 20-30 amines
(Fig. 2.26, left panel).
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Figure 2.26: PEGylation of isolated NCs and purified IpaB-TEV-Knot. Purified IpaB-TEV-Knot (left panel)
and isolated NCs (right panel) were either left untreated (-) or treated with 0.5 mM PEGylation reagent (+). West-
ern blot analysis was performed with anti-Strep tag mAB.
In comparison, IpaB-Knot isolated together with NCs showed much lesser PEGylation and
the protein size shifted not more than 10 kDa (Fig. 2.26, right panel). The difference in
PEGylation accessibility is most likely caused by the NC channel which confers protection
by surrounding IpaB-TEV-Knot, thereby partially covering the protein and shielding it against
proteases and chemical modifications.
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2.13 Initial single particle analysis of NCs with IpaB-Knot
cryo-EM images of NCs isolated from ∆ipaD::ipaBknot were recorded from 3 different
preparations and images suitable for single particle analysis were manually selected based
on image quality according to visibility of Thon rings, astigmatism, visible image drift and
contamination.
In total, 958 pictures were selected, yielding 2086 manually boxed single particles that were
further processed. An iterative rotational alignment based on cross-correlation scores of all
particles collected is depicted in Fig. 2.27A, where the first image (0) shows overlay of cen-
tered particles. After the initial rotational adjustment of single particles, further refinement
was performed with additional shifting of particles (Fig. 2.27B) Subsequently, particles were
classified into 12 different classes by k-means clustering based on needle length (Fig 2.28).
A
B
Figure 2.27: Rotational alignment of NCs. Computational iteration of particle alignment from left (no align-
ment) to refined alignment (right).
For some classes, an additional density was seen at the needle tip. However, in order
to substantiate this observation, more particles are required. Also comparison to control
particles (NC from ∆ipaD) without the fusion protein would be supportive to distinguishing
empty from obstructed NC. The preliminary data demonstrate that alignment of these par-
Chapter 2. Results 51
Figure 2.28: Single particle-analysis of isolated NCs. (A) Particle classes based on k-means clustering. (B)
Iterative alignment of all particles from 0 (manual alignment) to 9 (refined alignment).
ticles works with the approach taken, however, more data is required to obtain structural
information about the NC occupied with IpaB-Knot.
3 Discussion & Perspectives
The T3SS is an intricate bacterial secretion system with more than 25 structural proteins
constituting the machinery for protein transport across the membranes and the periplasm.
Many questions regarding the mechanism of secretion remain unanswered. Despite the ex-
tensive research on the driving force and substrate translocation, many details of effector
secretion are not known. A general assumption in the field is that effector proteins are un-
folded and secreted through a central channel in the structural part of the T3SS, the needle
complex. However, a formal experimental basis for this assumption has not been provided.
No experiments have addressed the localization of effectors during secretion using a direct
approach or visualized the effector inside the channel. This work aimed to gain experimental
insights into the secretion process by trapping an effector inside the needle during secretion.
Therefore, fusion proteins consisting of endogenous T3SS substrates and a knotted protein
domain were generated and studied in the context of the T3SS.
3.1 IpaB-Knot is a functional fusion protein
Obstruction of the channel by a knotted protein would occur if the Knot were inserted
into the channel and arrested during transport as it exceeds the channel dimensions. In si-
lico studies investigated translocation of knotted proteins in other protein transport systems
(Huang & Makarov, 2008; Dzubiella, 2009). Modeling of complex knots and a 6.5 Å channel
lead to the conclusion that a knot can be translocated. It was shown that distinct levels of
tightening occur over relative chain slippage in the entangled peptide and water molecules
leaving the knotted domain under higher forces applied on the peptide. It was also proposed
that the trefoil-knot motif has a radius of 6 to 11 Å under a maximal force of 1.5 nN (Dzu-
biella, 2009). A recent study focused on blocking mitochondrial import by a knotted protein
(Szymczak, 2013). Here, the modeling of a knotted protein being tightened by mitochondrial
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import lead to a gyration radius of the knot of 7 to 8 Å with the mitochondrial pore having an
inner diameter of 16 Å. As the inner diameter of the T3SS needle is 25 Å, this conformation
might even allow translocation of a trefoil-knot motif through the NC channel.
This implies that, in theory, the trefoil knot would be able to pass the channel of the T3SS,
assuming it has a maximal tightened conformation. However, the force acting on the peptide
during secretion largely influences the conformation of the Knot and thereby the diameter
of the trefoil-knot motif. It is not clear which force the T3SS applies to substrates during
transport, if it is a push or a pull mechanism by ATPase and proton motif force or the needle
channel itself, or how much it would squeeze the Knot within the fusion during secretion. The
in silico modeling approaches used high-force for translocation studies (70-400 pN). In com-
parison, the estimated translocase force is about 10 to 30 pN for ATP-dependent processes in
mitochondrial import or Sec-secretion in bacteria (Alder & Theg, 2003). Low-force studies are
difficult to model because of the longer simulation times required (Szymczak, 2013). Sug-
gesting that the force of T3SS is significantly lower than forces used in these simulations, the
Knot would stay partially relaxed, most likely with a diameter that exceeds the the channel
restrictions.
The trefoil-knot motifs in the chosen proteins are deep knots, which refers to knots that
are formed by a central peptide of the protein and thus, are unlikely to slide off the peptide
(Nureki et al., 2002; Virnau et al., 2011). This implies that the T3SS is unlikely to unwind the
knotted peptide during secretion. Hence, a knot protein fused to a native T3SS substrate
might have the capability to obstruct the T3SS.
Based on an initial analysis, the methyltransferase RrmA was chosen as an appropriate
knotted protein with a simple trefoil knot in its C-terminus. Expression of rrmA did not affect
secretion of T3SS effectors (Fig. 2.3). RrmA was fused to IpaB which resulted in the fusion
protein IpaB-Knot. It was possible that fusing IpaB to the Knot could destroy the functionality
of either domain. Therefore, assays were designed to probe the structure and function of
IpaB-Knot using purified protein.
It was shown previously that purified IpaB can recreate many aspects of Shigella inter-
actions with macrophages, including induced pyroptosis. This is an ideal assay to probe
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whether IpaB-Knot folds correctly, since the protein can be purified from the bacterium and
applied to host cells, bypassing the requirement for translocation through the T3SS (Fig. 2.4).
IpaB-Knot was applied to murine bone marrow macrophages and induction of pyroptosis was
quantified in a colorimetric assay (Fig. 2.5). Compared to previous studies, IpaB-Knot showed
a similar capacity to induce cell death (Senerovic et al., 2012), demonstrating that IpaB is still
functional in the fusion protein.
Folding status of the trefoil knot within the fusion was investigated using two complemen-
tary approaches. First, unfolding properties of IpaB-Knot were compared to native Knot. Flu-
orescence spectroscopy assesses the molecular environment of tryptophans which changes
during unfolding. Since IpaB contains only one tryptophan compared to four tryptophans
of Knot (of which three directly localize in the trefoil-knot motif), the major signal results
from the intrinsic fluorescence of the Knot domain. The spectrum of IpaB-Knot resembles the
native Knot spectrum and both curves overlay when proteins were completely unfolded by
adding chaotropic salt (Fig. 2.6). The similarity of fluorescence in the native state indicates
that the Knot folds properly in the fusion protein.
In a different approach, Knot folding was analyzed by limited proteolysis. Digestion of
native IpaB-Knot and Knot alone resulted in a fragment which was further cleaved, indicating
that both proteins contained stably folded core domains that were inaccessible to Proteinase
K (Fig. 2.7 and Fig. 2.8). This domain includes the trefoil-knot motif (Fig. 2.10). Since IpaB-
Knot and Knot provided comparable results in terms of unfolding and limited proteolysis, the
Knot folds into its native state when fused to IpaB.
With the characterization of the fusion protein, functionality of both domains within IpaB-
Knot was confirmed. Therefore, IpaB-Knot was the tool to investigate if a fusion protein with
a trefoil-knot domain could block the T3SS.
3.2 T3 secretion is attenuated by IpaB-Knot
In S. flexneri, the T3SS is regulated IpaB and IpaD. Wildtype bacteria do not secrete ef-
fector proteins in vitro but the T3SS can be artificially activated with Congo Red. It was first
addressed, if IpaB-Knot can block Congo Red-induced effector secretion in the ∆ipaB strain.
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The ∆ipaB mutant was complemented with either pipaB (plasmid-encoded wildtype IpaB) or
pipaBknot and secretion was compared under Congo Red-induced conditions. In contrast to
the ∆ipaB + pipaB strain, the strain carrying pipaBknot did not respond to Congo Red in-
duction (Fig. 2.11). Consistent with the idea that IpaB-Knot cannot pass through the T3SS,
IpaB-Knot was only found in bacterial lysates and was not secreted into culture supernatants.
Next, expression of pipaBknot was tested in the ∆ipaD mutant, which hypersecretes ef-
fectors including IpaB without induction by Congo Red. This bypassed the requirement for
Congo Red-induction and the effect of IpaB-Knot on T3 secretion was investigated in a strain
that constantly secretes effectors by default. pipaBknot or pipaB were expressed in addition
to endogenous ipaB (Fig. 2.12). While the expression of pipaB did not influence secretion
of other effectors, expression of pipaBknot completely eradicated effector proteins from the
supernatants and was not secreted itself. The secretion deficiency was at least partially be-
cause of reduced expression of other effectors. Even more so, IpaB-Knot reduced levels of
endogenous IpaB. This suggests that reduced effector expression is due to a feedback mech-
anism of IpaB as its cognate chaperone IpgC plays a crucial role in the regulatory cascade of
late effector expression (Schroeder & Hilbi, 2008). As long as IpgC is bound to IpaB and IpaC
in the bacterial cytosol, expression of late effectors, including the IpaH family, is downregu-
lated. Upon secretion of IpaB and IpaC, free IpgC activates the expression of late effectors
via MxiE. As IpaB-Knot is not secreted and remains bound to IpgC in the cytoplasm, the fusion
may completely deplete the IpgC pool and endogenous IpaB and IpaC are degraded, which
has been observed in the absence of IpgC (Menard et al., 1994b). Whether this phenotype
depends on IpgC only and might be circumvented by co-expression of ipgC remains to be
investigated.
In order to express ipaBknot under physiological conditions, the fusion allele was ex-
pressed under the native promoter of ipaB as it was intended to perturb the tightly regulated
effector cascade as little as possible. The fusion allele was inserted into the virulence plas-
mid in the ∆ipaD strain so expression did not require artificial induction but relied on the
endogenous promoter. Secretion of ∆ipaD::ipaBknot was compared to hypersecretion of
∆ipaD. Genomic expression of ipaBknot dramatically reduced effector secretion (Fig. 2.16).
Using the approach of genomic expression, synthesis of other early effectors like IpaC was
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not influenced. IpaC was expressed in similar amounts in all strains tested but was only se-
creted by the ∆ipaD strain. For ∆ipaD::ipaBknot, supernatants contained less IpaC. Again,
the regulatory effect of IpgC constantly bound to IpaB-Knot on late effector genes adds to
the phenotype of reduced effector secretion. Levels of the late effector IpaH were low in the
supernatant as well as in the lysate. The T3SS-independent extracellular protein SepA was
still secreted in the background of the ∆ipaD::ipaBknot strain, demonstrating that the effect
of IpaB-Knot is limited to the T3SS pathway.
Furthermore, invasiveness of the wildtype carrying ipaBknot (M90T::ipaBknot) was quan-
tified in comparison to wildtype M90T. Also levels of IpaB-Knot and the basal body protein
MxiG were compared to IpaB and MxiG levels in M90T (Fig. 2.14). ipaBknot rendered M90T
non-invasive to the extent of an ipaB-deficient strain. However, IpaB-Knot and IpaB levels
were equal in both strains as was the level of the basal body protein MxiG. This suggests sim-
ilar amounts of T3SS NCs and excluded that M90T::ipaBknot is attenuated in invasiveness
due to a lower expression of T3SS. Analysis of the secretion phenotype showed a deregu-
lated secretion compared to the wildtype, although M90T::ipaBknot partially responded to
Congo Red (Fig. 2.15), which implies that M90T::ipaBknot might not be able to form a proper
tip complex that regulates effector secretion.
In summary, IpaB-Knot is not secreted by S. flexneri but attenuates effector secretion
and also expression of late effectors. The reduction of effectors from the supernatant is most
likely a mixed phenotype resulting from impairment of the secretion pathway and limited
expression. This impairment is caused by IpaB fused to the Knot, as the expression of knot
independently from ipaB had no effect (Fig. 2.3 and Fig. 2.17).
Earlier studies concluded that fusion proteins impeding the T3SS arrest secretion by inter-
acting with the NC and obstruction of the channel (Feldman et al., 2002; Ghosh, 2004). Either
these fusion proteins directly block the channel (Feldman et al., 2002) or attenuated secre-
tion results from constant occupation of the ATPase which co-purified in pulldown assays and
is an essential component for T3SS (Sorg et al., 2006). Since the understanding of the se-
cretion mechanism is limited, it is possible that not the channel but essential components
like the ATPase were blocked by IpaB-Knot which would also inhibit secretion of effectors.
The next step was therefore to elucidate the mechanism by which IpaB-Knot interferes with
secretion.
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3.3 IpaB-Knot stably interacts with the NC
Analysis of effects on T3SS was continued by investigating whether or not decreased se-
cretion results from a direct interaction between the T3SS channel and IpaB-Knot. Separation
of proteins by zonal gradient centrifugation has been used to isolate intact T3SS from S. ty-
phimurium SPI-1 from soluble protein impurities (Schraidt & Marlovits, 2011). This strategy
was adopted to analyze interactions between IpaB-Knot and the NC. In isolates from ∆ipaD,
IpaB does not interact with the NC as IpaD provides the binding site for IpaB. Consequently,
soluble IpaB remained in the low density-fraction whereas high molecular weight complexes
like the NC migrated to high density-fractions (Fig. 2.18). In contrast to ∆ipaD, isolated
NCs from∆ipaD::ipaBknot showed a clear co-localization with IpaB-Knot in high-density frac-
tions. This was not observed for purified IpaB-Knot added to isolated NCs from ipaD, where
IpaB-Knot remained in low- to medium-density fractions with the latter possibly containing
aggregated IpaB-Knot (Fig. 2.18C and D, CsCl fraction 3).
Two conclusions regarding the interaction between IpaB-Knot and the NC can be drawn
from this experiment. First, IpaB-Knot interacts with components of the NC as IpaB-Knot and
MxiG co-migrate to high-density fractions. Second, this interaction is mediated by a mech-
anism depending on the bacterium as it cannot be restored by adding purified IpaB-Knot to
isolated NCs from ∆ipaD.
It is possible that the mechanism that mediates IpaB-Knot interaction with the NC is at-
tempted secretion by the T3SS. If IpaB-Knot is secreted with the N-terminus first and secre-
tion occurs through the NC channel, this terminus would protrude from the needle and thus
could be antibody-labeled. The T3SS needle dimensions require effectors to be unfolded
prior to secretion as no globular domains could pass through the 2.5 nm channel. After being
released from the channel, the effector domain might fold back into its native conformation,
as it was shown that IpaB spontaneously forms oligomers when released from the chaperone
IpgC (Senerovic et al., 2012). The total length of 580 amino acids and a tendency to adopt
a helical conformation (which complies with the inner diameter of the NC) restrict IpaB to
87 nm from N- to C-terminus. The prediction of a helical structure is based on a partial x-ray
structure analysis (Adam et al., 2012), which showed IpaB forming helical bundles, and is in
agreement with in silico analyses using a protein structure prediction tool (Fig. 3.1). Together
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with the Knot domain being to some extent engaged into the channel, it is most likely that
the IpaB mAB epitope, which localizes between residues 118 and 179 (Barzu et al., 1993),
protrudes from the needle and is accessible to antibody-labeling.
Figure 3.1: ProteinPredict analysis of IpaB amino acid sequence. Yellow/blue fragments correspond
to exposed and buried stretches, respectively. Red bars indicate helical stretches, pink bars refer to trans-
membrane domains.
Considering that the first 150 amino acids (which contain the IpaB epitope) need to be
outside the NC, the length of the remaining unfolded IpaB is limited to 64,5 nm. This stretch
is extended by partial insertion of the Knot fused to IpaB C-terminus. The length of the NC
in S. flexneri usually ranges from 70 to 80 nm in total (Tamano et al., 2000; Magdalena et al.,
2002; Tamano et al., 2002). This implies that IpaB N-terminus and the C-terminal Strep-tag
should be accessible to antibody-labeling.
In agreement with this initial theoretical approach was the observation that labeling of
IpaB occurred either close to the tip or the base of the NC (Fig. 2.19). As there were no gold
particles seen in the negative control, isolated NCs from ∆ipaD (data not shown), specificity
of gold particle labeling on NCs was determined by a nearest-neighbor analysis (Fig. 2.20).
Comparing random distributions of gold particles to the distribution observed in labeling ex-
periments, distances between gold and the nearest NC were quantified. The outer membrane
ring was chosen as an NC coordinate as it lies in the middle of the NC. For distances between
the outer membrane ring and gold particles, values around 30 to 50 nm were observed. This
corresponds to half the NC length including variation by antibodies and gold particle radius
(up to 16 nm (Amiry-Moghaddam & Ottersen, 2013)).
Labeling of IpaB occurred at both the distal and the basal side of the NC. The IpaB N-
terminus being detected at needle tips supports the linear model of secretion with the N-
terminus mediating secretion and being released from the NC first. For localization of IpaB
N-terminus at the basal body side, one might speculate that IpaB-Knot is kept at the C-ring
or the sorting platform, potentially by the ATPase. As the N-terminus is accessible to gold-
labeling, it is not clear which part of the effector interacts with the NC in this state. This
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might indicate an additional secretion signal downstream of the primary N-terminal signal
sequence which interacts with the channel in a looped conformation while the N-terminus
remains at the base until a stable interaction between this loop and NC is established. A
more complex motif has been suggested for a recognition signal in earlier studies, where the
secretion signal fused to a reporter was not sufficient for secretion but an additional stretch
including the chaperone binding domain was required (Wilharm et al., 2004a; Riordan et al.,
2008). Further experiments are necessary to understand the way effectors are engaged into
the channel and which part is ultimately recognized by the T3SS prior to secretion.
Only 20 to 25 % of the overall NC population isolated from the bacterial membrane were
labeled with gold. It is not clear whether this was due to technical limitations or if only a
subpopulation of the isolated NCs occupy IpaB-Knot. Therefore, NCs interacting with IpaB-
Knot were selectively enriched by additional affinity purification via the C-terminal Strep-tag
of the fusion protein. This lead to isolation of NCs that lacked parts of the basal body and
merely consisted of the central channel (Fig. 2.21). It is noteworthy that the fusion protein
was still localized at these NCs. This suggests that the intrinsic interaction between IpaB-
Knot and the channel is stronger than the interactions between basal body components of
the NC. Still, frequent gold-labeling occurred, indicating that the low number of gold-positive
NCs was rather due to technical reasons as these NCs were isolated based on their interac-
tion with IpaB-Knot. Opposing the altering localization of the IpaB N-terminus at needle tips
or bases, localization of IpaB-Knot C-terminal Strep-tag occurred only at the basal side of NCs
or isolated channels (Fig. 2.22). This suggests that, in comparison to the N-terminus of the
fusion, the C-terminus is less flexible during the process of secretion, perhaps because the
Knot domain blocks the T3SS and thereby keeps the C-terminus of the fusion localized at the
entry port of the channel.
To elucidate the orientation of IpaB-Knot interacting with the NC, simultaneous detec-
tion of both termini of the fusion was performed. As one cannot distinguish both primary
antibodies generated in mouse in this approach, the IpaB antibody was transformed into a
human IgG. The recombinant humanized monoclonal IpaB antibody was not recognized by an
anti-mouse secondary antibody (Fig 2.23). Consequently, humanized anti-IpaB and mouse
anti-Strep mABs can be labeled with species-specific secondary antibodies coupled to dif-
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ferent gold particles. Dual localization of N- and C-terminus using both primary antibodies
occurred reproducibly but was a rare event (Fig. 2.24). Immuno-labeling on single proteins
using either IpaB or Strep mAB was not very efficient and therefore, labeling with two an-
tibodies binding to each epitope on the same protein becomes technically unlikely. Further
refinement of the labeling strategies is necessary in order to improve rates of labeling, for
example with pre-conjugated primary/secondary antibody complexes or gold-conjugated pri-
mary antibodies, might help improving the rate of simultaneous N/C-terminus detection. Still,
these experiments show the orientation of IpaB-Knot to be N-terminus at the NC tip and the
C-terminus at the corresponding NC basal body.
3.4 IpaB-Knot is secreted through the NC channel
The observed gold localization at isolated NCs suggests secretion depending on the T3SS,
but it does not necessarily imply secretion through the channel according to the model that
the NC is a conduit for protein transport. An alternative model has been discussed in earlier
studies where the needle guides the effectors towards the host cell in the plant pathogen
Pseudomonas syringae pv. tomato along the T3SS Hrp pilus protruding from the bacterium
(Jin & He, 2001) (Fig. 3.2).
These two models derived from the observation that the effector AvrPto was detected
along the entire pilus as being stored on the pilus surface. The guiding-filament versus con-
duit function of the extracellular appendage was further analyzed by gold-labeling of effec-
tors that accumulated at the tip of the pilus when their expression was uncoupled and de-
layed from pilus formation (Jin et al., 2001; Li et al., 2002). These analyses favor the conduit
model but do not exclude the guiding-filament model which would also be in agreement with
the recent studies where effectors were stored on the outer membrane of Yersinia (Ghosh,
2004; Akopyan et al., 2011; Edgren et al., 2012). In case the fusion localizes inside the NC
channel, its access to modifications should be limited by the surrounding channel. In order
to test this hypothesis, a TEV protease-recognition site was inserted between IpaB and Knot
resulting in IpaB-TEV-Knot. If the site localizes inside the NC past insertion of the effector, the
channel would protect it, whereas, if the recognition site is accessible, the protein should be
digested. IpaB-TEV-Knot co-purified with NCs was not cleaved by an excess of TEV protease,
whereas purified IpaB-TEV-Knot was digested already at low concentrations (Fig. 2.25). The
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Figure 3.2: Models proposed for the T3SS mechanism. (A) The conduit model where effectors (blue) are
unfolded and secreted through the NC channel. (B) The alternative guiding-filament model where effectors are
translocated across the bacterial membrane by an unknown mechanism and guided along the needle of the NC.
OM = outer membrane, PP = periplasm, IM = inner membrane.
limited proteolysis is most likely because of protection or sterical hindrance mediated by the
channel interacting with and protecting the protein. However, it cannot be fully excluded
that the fusion protein was arrested in a conformation that does not allow TEV cleavage but
is still secreted outside the NC channel.
To further analyze exposure of IpaB-TEV-Knot, NCs occupied with IpaB-TEV-Knot were
treated with MS(PEG)24, a crosslinking reagent with an engineered PEG moiety. The PEGy-
lation reagent adds PEG of discrete molecular weight and length (1.1 kDa/86.2 Å) to primary
amines and diffusion into the needle channel is unlikely for sterical reasons. A difference in
PEGylation of NCs compared to purified IpaB-TEV-Knot of approximately 15 to 30 PEGylation
events was observed when treated with 0.5 mM MS(PEG)24 (Fig. 2.26). At lower concentra-
tions, no PEGylation was detectable whereas higher concentrations lead to maximal PEGyla-
tion of both samples, probably caused by the increased amount of solvent (DMSO) affecting
the channel integrity (data not shown). The limited accessibility of the evenly distributed
primary amines in IpaB-TEV-Knot to chemical modifications demonstrates protection of the
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fusion protein conferred by the channel. At this point, it remains elusive which residues of
the protein are exposed to PEGylation, however, this approach might help understanding
which parts of the protein are protected by the channel if combined with for example mass
spectrometric analyses in the future.
Together with data from immuno-labeling of IpaB-Knot at isolated NCs, the PEGylation
experiments bespeak shielding of the fusion protein by the channel which physically encloses
the substrate. Both termini of IpaB-Knot were detected at each side of isolated NCs and
furthermore, IpaB-TEV-Knot is protected from site-specific proteolysis and less exposed to
chemical modifications compared to purified fusion protein.
3.5 Towards structural data of active T3SS:
Initial single particle analysis
Structural analysis using cryo-electron microscopy and single particle analysis revealed
the conformation of the NC from S. typhimurium SPI-1 (Schraidt & Marlovits, 2011) and S.
flexneri (Hodgkinson et al., 2009). In addition to analyses of isolated complexes, a recent
study investigated the conformation of NCs from Yersinia and Shigella in the bacterial enve-
lope in situ. Interestingly, NCs inside the membrane were up to 40 % shorter compared to
structural analysis of isolated particles (Kudryashev et al., 2013). Such in situ-observations
reveal important details on structural interactions inside the macromolecular complex.
However, for the isolated S. typhimurium SPI-1 and S. flexneri NC, both complexes were
empty and therefore, these studies only addressed conformations of inactive channels. By
investigating constantly occupied NCs, structural analysis of these particles has the potential
to elucidate details of interactions between substrate and NC. This would include conforma-
tional changes of the channel components during secretion. Therefore, isolated particles
from the∆ipaD::ipaBknot strain were subjected to an initial single-particle analysis following
cryo-EM imaging. Manually selected particles were grouped based on the needle length after
k-means analysis. This resulted in 12 different classes of particles, of which some indicated
additional densities at the needle tip (Fig. 2.27). However, as the particle number was too
low to confirm this, it is not evident that the potential density is a protruding protein. More
particle input is required for further analysis and validation of this initial study.
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The standards for cryo-EM samples are high and criteria include a homogeneous distribution
of particles, low background and ice of suitable quality and diameter. The samples were of
poor quality for cryo-EM analysis as a granular, heterogeneous background was frequently
observed. One possible source was the detergent included, as it forms micelles at certain
concentrations which could affect the background. The purification of NCs without detergent
leads to particle aggregation, therefore a strong detergent like Triton X-100 has proven to be
indispensable for this process. Different detergents for purification were tested, which have
a higher critical micelle concentration (CMC) but purification of NCs below the CMC was not
successful yet. This process needs to be improved in order to obtain valid data based on
sufficient single particles for either 2D or 3D structural analysis.
So far, these results show that the principle of single particle analysis works for isolated
occupied NCs, as the iterative alignment based on cross-correlation values was applicable to
isolated particles. With samples that are of better quality, this might lead to structural data
on NCs arrested in the process of secretion in the future.
3.6 Conclusion
This work provides an experimental basis for the widely assumed mechanism of T3SS se-
cretion. It was demonstrated that IpaB-Knot is partially secreted through the NC, albeit not
released from the channel due to secretion arrest by the Knot domain, and that the channel
surrounds and shields the fusion protein. Transport occurs with the N-terminus first as our
constructs do not allow secretion by the C-terminus because of the C-terminal Knot fusion.
The N-terminus could be detected at the distal end of the NC needle portion as it protrudes
from the channel. Both termini of IpaB-Knot were detected on each side of isolated NCs. This
is, as far as one can tell, the first visualization of an effector localized at isolated NCs and it
implies that effector proteins are secreted through the T3SS channel. Regarding the localiza-
tion of the N-terminus on either tip or basal side of the NC, the following model for effector
secretion attempts to describe these observations. The effector is bound to the chaperone
and presented to the T3SS basal side, where an interaction partner (for example the sorting
platform including the ATPase) recognizes the effector/chaperone complex (Fig. 3.3).
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Figure 3.3: Model of effector insertion and secretion. (A) The effector fusion (blue and orange) interacts
with a cytoplasmic component where a part of the effector is inserted into the NC but the Knot inhibits further
secretion. (B) Secretion arrested at a later stage of insertion with the effector protruding from the channel.
An N-terminal stretch is inserted into the channel, however, the signal sequence remains
outside and eventually, the Knot blocks further secretion. The N-terminus is secreted across
the channel with the Knot remaining on the cytosolic side. This model is in line with the
observation that the signal was in some cases not sufficient to mediate secretion of fusion
constructs that in turn failed to obstruct the system (Lee & Schneewind, 2002; Riordan et al.,
2008).
Combined with structural analysis, this approach could lead to novel insights into the
conformation of a T3SS channel during the process of secretion. This strategy is transferable
onto other secretion or translocation systems which require unfolding of the substrate during
secretion. As channels could be isolated based on the interacting substrate, other channels
might be isolated and investigated using a similar approach.
4 Materials & Methods
4.1 Kits, Chemicals & Machinery
The commercially available kits, fine chemicals, reagents and machines used in the ex-
periments during this study are listed below. Kits (table 4.1) were used according to manufac-
turers instructions. Fine chemicals were purchased in pro analysis (p.a.) quality, if available.
Chemicals include ready-mixtures for bacterial and cell-culture media.
Table 4.1: Commercially available kits
Designation Manufacturer
Zyppy DNA Plasmid prep Zymo Research
Gel DNA Recovery Zymo Research
DNA Clean & Concentrator Zymo Research
RNeasy Mini Kit QIAGEN
SuperSignal West Pico ECL
enhancer
Thermo Scientific
Table 4.2: Machines used during the study
Device Designation Manufacturer
Centrifuge Avanti J-20 XP/J-25 Beckman Coulter
Centrifuge Heraeus Multifuge 3SR Thermo Scientific
Centrifuge Centrifuge 5415 /R Eppendorf
Camera (TEM) Soft Imaging System Olympus
CO2 incubator ThermoForma Direct Heat CO2 Thermo Scientific
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Device Designation Manufacturer
Coating System MCS010/MED020 Bal-Tec
Electroporation
System
Gene Pulser II Bio-Rad Laboratories
GmbH
Coffee Machine SPIDEM Trevi Chiara Saeco GmbH
FPLC ÄKTA FPLC + P-920, UPC-900,
Frac-920
GE Healthcare
Gel Imaging AlphaImager™ fomerly Alpha Innotec
Fluorescence
Spectrometer
LS-55 PerkinElmer
HPLC ÄKTA Explorer + P-900, UV-900,
PH/C-900, Frac-950
GE Healthcare
Incubator Innova 44/R New Brunswick
Scientific/Eppendorf
PCR Cycler C1000™ Bio-Rad Laboratories
GmbH
Spectrophotometer MDS SpectraMAX 190 Molecular Devices GmbH
Spectrophotometer NanoDrop 2000 PEQLAB Biotechnologie
GmbH
TEM LEO 906E Carl Zeiss
Thermomixer Thermomixer compact Eppendorf
Ultracentrifuge Optima L-90K Beckman Coulter
Ultracentrifuge Optima MAX Beckman Coulter
UV Table UV Transilluminator 312nm INTAS Science Imaging
Instruments GmbH
ECL Detection ImageQuant LAS 4000 GE Healthcare
Table 4.3: Chemicals used during the study
Designation Manufacturer
Agarose for DNA electrophoresis SERVA
Ampicillin Sigma Aldrich
Anhydrotetracyclin (AHT) Thermo Fisher
Chloramphenicol Sigma Aldrich
Bromophenol Blue Sigma Aldrich
Congo Red Sigma Aldrich
Coomassie Brilliant Blue G-250 SERVA
Desthiobiotin IBA
Dithiothreitol (DTT) Enzo Life Sciences
Ethidium bromide (EtBr) Sigma Aldrich
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Designation Manufacturer
Imidazole ultra-pure Roth
Isopropyl-β-D-thiogalactopyranosid (IPTG) Fermentas
Kanamycin Sigma Aldrich
Lauryldimethylamine N-oxide (LDAO) Sigma Aldrich
N-Lauroylsarcosine (Sarkosyl) Sigma Aldrich
Lysogeny broth (LB) medium (Luria/Miller) Roth
LB agar Roth
n-Octyl-β-D-Glucopyranoside (OG), Anagrade Affymetrix
NanoVan Nanoprobes
Triton X-100 Sigma Aldrich
Tween20 Applichem
Tryptic soy broth (TSB) medium Sigma Aldrich
Xylene Cyanol FF SERVA
4.2 Buffer solutions
Buffers specific to experiments are included in the respective section in this chapter.
Common buffer solutions and growth media are listed below. Standard buffer recipes are
taken from Sambrook & Russel (2001).
Table 4.4: List of standard buffers
Designation Ingredients
PBS 137 mM NaCl
2.7 mM KCl
4.3 mM Na2HPO4
1.47 mM KH2PO4
TAE 40 mM Tris acetate, pH 8.0
1 mM EDTA
DNA loading dye (6x, 10 ml) 25 mg Bromophenol Blue
25 mg Xylene Cyanol FF
3.3 ml Glycerol
6.7 ml ddH2O
Towbin buffer 25 mM Tris base
192 mM Glycine
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Designation Ingredients
20 % (v/v) Methanol
PBS-T PBS
0.05 % (v/v) Tween20
Laemmli sample buffer 80 mM TrisHCl, pH 6.8
2 % (v/v) SDS
10 % (v/v) Glycerol
10 mM DTT
0.25 % (w/v) Bromophenol Blue
Coomassie stain 10 % (v/v) Isopropanol
13 % (v/v) Acetic acid
0.1 % (w/v) Coomassie Brilliant
Blue G 250
Destain solution 10 % (v/v) Isopropanol
13 % Acetic acid
Tris-glycine SDS running buffer 25 mM Tris base
192 mM Glycine
3.5 mM SDS
4.3 Bacteria & DNA
All bacteria that were either used or generated during this study are listed below in table
4.5, DNA plasmids in table 4.6. Oligonucleotides used for qualitative DNA analysis, genetic
modifications or generation of plasmid constructs were synthesized by MWG Eurofins and are
listed in table 4.7. E. coli BL21 DE3 was used for protein purification following overexpres-
sion of the respective gene, E. coli GC10 was used for plasmid preparations and cloning of
constructs listed in table 4.6.
Constructs with pASK-IBA3+ carry a 3’ strep-tag, constructs with pASK-IBA33+ a 3’ 6his-
tag and confer resistance to ampicillin. These constructs have a tet-promoter and are in-
ducible with anhydrotetracyclin (AHT). pET28a has a kanamycin resistance cassette and at-
taches a 3’ 6his-tag to the inserted gene. Expression under the pET28a lac-promoter is
induced by IPTG. The sequence of knot1 is derived from ”conserved protein MT0001” (here
termed Akp1) from Methanobacterium thermoautotrophicum (PDB ID: 1K3R), the sequence
of knot2 or knot, respectively, is derived from RrmA from Thermus thermophilus (PDB ID:
1IPA). Plasmids and oligonucleotides that are designated ”rrmA” thereby refer to knot and
vice versa. For amplification of knot1 and knot2, the protein sequences of Akp1 and RrmA
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were reverse-translated in silico and codon-optimized for E. coli K12 by MWG Eurofins. The
genes were synthesized with a 5’ PstI site and a 3’ NcoI site and TOPO-cloned into pCR2.1 by
MWG Eurofins.
Table 4.5: Bacterial strains used in this study.
Bacterial strain Genotype Source
Shigella flexneri M90T wildtype strain, serovar 5a isolate Sansonetti et al.
(1982)
S. flexneri ∆ipaB M90T ipaB- Lab collection
S. flexneri ∆ipaD M90T ipaD- Lab collection
S. flexneri ∆mxiH∆ipaD M90T mxiH-,ipaD- Lab collection
S. flexneri M90T::ipaBknot M90T with ipaBknot fusion allele This study
S. flexneri ∆ipaD::ipaBknot M90T ipaD-, with ipaBknot fusion
allele
This study
S. flexneri ∆ipaD::ipaBTEVknot with ipaBTEVknot fusion allele This study
Escherichia coli BL21 DE3 &F- ompT hsdSB(rB-, mB-) gal dcm Invitrogen
E. coli GC10 F- mcrA ∆(mrr-hsdRMS-mcrBC)
φ80dlacZ∆M15. ∆lacX74 endA1
dam ∆(ara, leu)7697 araD139
galU galK nupG rpsL λ - T1R
Sigma
The Shigella mutant strains ∆ipaB, ∆ipaD and ∆mxiH∆ipaD have been kindly provided
by Anna Brotcke, MPIIB, Department for Cellular Microbiology.
Table 4.6: Plasmid DNA used in this study.
Plasmid backbone Insert
pCR2.1 akp1 (henceforth: knot1)
pCR2.1 rrmA (henceforth: knot or knot2)
pASK-IBA33+ knot1
pASK-IBA33+ knot2
pASK-IBA3+ ipaBknot
pASK-IBA3+ ipaB
pASK-IBA3+ ipaBTEVknot
pET28a ipgC
pKD3 chloramphenicol cassette for gene
targeting
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Plasmid backbone Insert
pKM208 FLP recombinase for gene
targeting
gamma1 IpaB mAB gamma chain
kappa1 IpaB mAB kappa chain
The plasmid pET28a-ipgC has been published before in Lunelli et al. (2009), as well as pKD3
and pKM208 in Datsenko & Wanner (2000). Plasmids backbones for recombinant IgG ex-
pression have been provided by the Wardemann lab, MPIIB, and are described in Tiller et al.
(2008) and Tiller et al. (2009).
Table 4.7: Oligonucleotides used in this study.
Name Sequence (5’ to 3’) Description
BsaI-akp1-Fw AGC AGA GGT CTC TA ATG AAT CGC GTT
GAT CTT TCC CTG TTC
cloning knot1 w BsaI in
pASK-IBA
BsaI-akp1-Rv AGA CAC GGT CTC TGC GCT TTC GTC
TTT CTC GTC G
cloning knot1 w BsaI in
pASK-IBA
BsaI-rrmA-Fw AGC AGA GGT CTC TA ATG CGC ATT ACC
TCA ACG GCG AAT C
cloning ipaB w BsaI in
pASK-IBA
BsaI-ipaBrrmAST-Fw AGC AGA GGT CTC TA ATG CAT AAT GTA
AGC ACC ACA ACC T
cloning ipaB w BsaI in
pASK-IBA
BsaI-ipaBrrmAST-Rv AGA CAC GGT CTC TGC GCT AAG CGT
CGA ATG GGT
cloning knot2 (knot) w
BsaI in pASK-IBA
ipaBPstIrrmA-Fw TAC TGC TCT GCA GAT GCG CAT TAC
CTC AA
forward fusion primer
for ipaB & knot
ipaBPstIrrmA-Rv GCG CAT CTG CAG AGC AGT AGT TTG
TTG CA
reverse fusion primer
for ipaB & knot
BsaI-rrmA-Fw AGC AGA GGT CTC TA ATG CGC ATT ACC
TCA ACG GCG AAT C
cloning knot w BsaI in
pASK-IBA
iBrrmA-Cm usF AGC CTC AAT GTC CAA CTC TCA GGC
TAA TAG AAC TGA TGT TGC AAA AGC
AAT TTT GCA ACA AAC TAC TGC TAT
GCG CAT TAC CTC AAC GGC G
upstream flanking
primer for knot fusion
to ipaB in pWR100
iBrrmA-Cm usR GGA CCA TGG CTA ATT CCC ATT TAT TAT
TTT TCG AAC TGC G
forward fusion of knot
and cam
iBrrmA-Cm dsF CGC AGT TCG AAA AAT AAT AAA TGG
GAA TTA GCC ATG GTC C
reverse fusion of knot
and cam
iBrrmA-Cm dsR GGA TAT ATC TGT ATA TAA AGT CTG GGT
TGG TTT TGT GTT TTG AAT TTC CAT AAC
ATT CTC CTT ATT TGT AGT GTA GGC TGG
AGC TGC TTC
downstream flanking
primer for knot
insertion in pWR100
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Name Sequence (5’ to 3’) Description
iBTrrmA-Cm usF AGG CTA ATA GAA CTG ATG TTG CAA
AAG CAA TTT TGC AAC AAA CTA CTG
CTG AAA ACC TTT ATT TTC AGT CTA TGC
GCA TTA CCT CAA CGG CG
upstream flanking
primer for TEVknot
insertion in pWR100
ipaB TAA rrmA F TCC AAC TCT CAG GCT AAT AGA ACT
GAT GTT GCA AAA GCA ATT TTG CAA
CAA ACT ACT GCT TAA TAC AAA TAA
GGA GAA TGT TAT GCG CAT TAC CTC
AAC GGC
upstream flanking
primer for knot
insertion with
ipaC-RBS in pWR100
iBrAC short F AGC CTC AAT GTC CAA CTC TCA GG short forward primer
for knot-cam and
TEVknot-cam PCR
iBrAC short R GGA TAT ATC TGT ATA TAA AGT CTG GGT
TGG
short reverse primer
for knot-cam and
TEVknot-cam PCR
insert seq Fw ATT CGG CCA ATT GCA GGA AG insert check for ipaB
fusions
insert seq Rv AAT GTG GTT GTT AAT ACG GG insert check for ipaB
fusions
msVHE GGG AAT TCG AGG TGC AGC TGC AGG
AGT CTG G
universal murine
gamma forward
mCh-g1-outer GGA AGG TGT GCA CAC CGC TGG AC murine Ig constant
region (gamma chain),
semi-nested outer
primer, reverse
mCh-g1-inner GCT CAG GGA AAT AGC CCT TGA C murine Ig constant
region (gamma chain),
semi-nested inner
primer, reverse
P-mVH02 CTG CAA CCG GTG TAC ATT CCC AGG
TGC AGC TGC AGC AGT CTG G
specific gamma
segment (with AgeI
site), forward
mJh3-SalI-rev TGC GAA GTC GAC GCT GCA GAG ACA
GTG ACC AGA G
specific gamma
segment
mVkappa GAY ATT GTG MTS ACM CAR WCT MCA universal murine
kappa forward
mCkappa-outer ACT GAG GCA CCT CCA GAT GTT murine Ig constant
region (kappa chain),
semi-nested outer
primer, reverse
mCkappa-inner TGG GAA GAT GGA TAC AGT T murine Ig constant
region (kappa chain),
semi-nested inner
primer, reverse
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Name Sequence (5’ to 3’) Description
P-mVk03 CTG CAA CCG GTG TAC ATT CCC AAA
TTG TTC TCA CCC AGT CTC CA
specific kappa
segment (with AgeI
site), forward
mJk5-BsiWI-rev GCC ACC GTA CGT TTC AGC TCC AGC
TTG GTC
specific kappa
segment
5’ Ab sense GCT TCG TTA GAA CGC GGC TAC sequencing subcloned
murine Ig, forward
3’ IgG internal GTT CGG GGA AGT AGT CCT TGA C sequencing heavy
chain, reverse
3’ Cκ 494 GTG CTG TCC TTG CTG TCC TGC T sequencing kappa,
reverse
4.4 Enzymes
All enzymes for DNA manipulation, including restriction enzymes, ligases and polymerases
were obtained from New England Biolabs or Rapidozym and used according to manufactur-
ers instructions. A list of enzymes for DNA and protein manipulation which were used in this
study is given in table 4.8.
Table 4.8: Enzymes used in this study.
Name Manufacturer
DNA-modifying enzymes
Restriction endonucleases New England Biolabs
T4 DNA Ligase New England Biolabs
QuickLigase New England Biolabs
Phusion Polymerase New England Biolabs
Taq Polymerase Rapidozym
Superscript III Reverse Transcriptase Invitrogen
Protein-modifying enzymes
Trypsin Sigma
Proteinase K Sigma
TEV protease R&D Diagnostics
Lysozyme 10 mg/ml stock Novagen
4.5 Cellular Methods
4.5.1 General cell culture
HeLa cells were obtained from the DSMZ (Acc. 57, lot 16). The cells were passaged
at a confluescence of 75 % and maintained in Dulbecco medium (DMEM, Life Technologies)
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supplemented with 10 % fetal calf serum (FCS), 100µg/ml Penicillin/Streptomycin (Pen/Strep),
1 % Pyruvate and 2 mM L-glutamine (DMEM complete).
Murine bone marrow macrophages were isolated from C57BL/6J mice (The Jackson Lab)
and kept in liquid nitrogen. Before experimental work, cells were seeded into 96-well plates
(Nunc).
HEK293T cells were grown in 150 mm petri dishes in DMEM complete. Medium was re-
placed by 25 ml of DMEM supplemented with 1 % Nutridoma-SP (Roche) prior to polyethyleneimine
(PEI)-mediated transfection.
4.5.2 Cytotoxicity assay
IpaB cytotoxicity was quantified as described before (Senerovic et al., 2012). Murine
bone marrow macrophages (mBMM) from C57BL/6J mice (Jackson Lab) were seeded in 96-
well plates (105 mBMM/well) in DMEM with 2 % FCS and incubated overnight. Medium was
replaced with DMEM with reduced FCS (0.5 %). Different concentrations of recombinant IpaB-
Knot or bovine serum albumin (BSA) were added to cells. The cells were then incubated for
2 h at 37 °C. Supernatants were collected and analyzed for the presence of lactate dehydroge-
nase (LDH) using a colorimetric assay (Cytotox96, Promega) according to the manufacturers
instructions.
4.5.3 Gentamicin protection assay
Invasion of Shigella strains was quantified as described previously (Sansonetti et al.,
1986). 105 HeLa cells per well were seeded in 24-well plates and grown overnight in DMEM
complete. Cell culture medium was exchanged the next day to 500 µl DMEM without Pen/Strep
(DMEM-P/S). HeLa cells were infected with 107 bacteria (log phase) in 100 µl PBS and cen-
trifuged at 1.340 rcf for 10 min. Infection occurred for 30 min at 37 °C, 0.5 % CO2. Medium
was exchanged to DMEM-P/S + 50 µg/ml gentamicin to avoid continuous reinfection and bac-
teria were allowed to replicate inside cells for 2 h at 37 °C. HeLa cells were then washed with
PBS and lysed in the presence of 1 % (v/v) Triton X-100 in PBS and dilutions were plated on
LB agar. Bacterial invasion was quantified by number of colony-forming units (CFU) per ml
culture after overnight incubation at 37°C.
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4.6 Molecular Methods
4.6.1 Polymerase Chain Reaction (PCR)
DNA was amplified with commercially available enzymes. All reactions for cloning were
carried out using Phusion High-Fidelity DNA Polymerase (New England Biolabs) according
to manufacturers instructions. For analytical PCRs, Taq polymerase (Rapidozym) was used.
Primer were used at a concentration of 0.4 mM per reaction, template DNA was used at 10-
100 ng per reaction. For amplification, DNA was initially denatured at 95 °C, followed by
another short denaturation (15 sec), annealing (30 sec) and elongation (1 min/kb). The latter
three steps were repeated for 25-35 cycles and finished with a final elongation of 7 min.
For site-directed mutagenesis, an initial program consisting of three cycles as mentioned
above was run with the reverse and the forward primer in separate reactions. After the initial
program, the forward and corresponding reverse reactions were mixed 1:1 and additional
polymerase (2 units of Phusion polymerase) was added. The program was then continued for
35 cycles.
4.6.2 Gene Targeting with linear DNA products
According to the method described by Datsenko & Wanner (Datsenko & Wanner, 2000),
genes can be efficiently targeted for a deletion or insertion using linear DNA products and
recombinase-mediated insertion. The DNA product encodes for flanking regions of the gene
of interest, or an insertion product flanked by upstream and downstream sequences of the
insertion site. Both products are fused by PCR to an antibiotic cassette. Bacteria were initially
transformed with the pKM208 plasmid which encodes for a FLP recombinase. In a subculture,
expression of the FLP recombinase was induced with 2 mM IPTG at an OD600 of 0.1-0.15/ml.
After one hour, bacteria were harvested and washed once with ice-cold ddH2O and once
with 20 % glycerol. The bacteria were transformed with up to 1 µg purified PCR product and
recovered in 1 ml TSB medium after electroporation for 1.5-2 h at 37 °C. Growing at 37 °C
cures bacteria from the pKM208 plasmid. Subsequently, bacteria were plated on TSB with
the respective antibiotics. Positive clones were checked by analytical PCR using a subculture
as direct template.
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4.6.3 Conventional agarose gel electrophoresis
Linear DNA products between 200 bp and 8 kb were analyzed by constant field elec-
trophoresis using 1-1.2 % agarose gels in TAE buffer. Agarose (SERVA) was molten in TAE
buffer using a microwave (600 W, 2-3 min). The mix was supplied with EtBr (3 µl/ml), poured
into gelcasts and allowed to cool down for 30-60 min at RT. Preparative and analytic elec-
trophoresis were performed at 100-140 V. Bands were visualized using a UV cabinet (AlphaIm-
ager) or a UV table (BalTec) for excision. Eurogentec SmartLadder was used as a standard
with 5 µl per lane.
4.6.4 Standard cloning of plasmid constructs
Plasmid constructs were generated by ligation of PCR-generated inserts into plasmid
backbones. PCR amplicons were purified from the reaction by preparative agarose gel elec-
trophoresis and Zyppy Gel DNA recovery kit. The amplicon as well as 1 µg of the plasmid
backbone were digested with restriction enzymes according to manufacturers recommenda-
tions. For standard DNA digestion, 20 units per 50 µl reaction were incubated for 1 h at 37 °C.
Amplicons were purified with Zyppy Clean & Concentrator kit, plasmid backbones were sep-
arated from the digestion product by preparative agarose gel electrophoresis. Ligation was
performed using either T4 DNA Ligase or the QuickLigation kit (both New England Biolabs).
4.6.5 Cloning and expression of murine Ig genes
Cloning and expression of recombinant murine Ig genes was performed in collaboration
with the Wardemann lab, MPIIB Berlin, according to the procedure described by Tiller et al.
(Tiller et al., 2008, 2009). The protocol consists of two steps, reverse transcriptase-PCR (RT-
PCR) and subsequent cloning of the respective heavy and light chain gene segments followed
by in vitro expression in HEK293 cells.
RT-PCR and subcloning
Total RNA from 106 H16 hybridoma cells producing IpaB monoclonal antibody (mAB) was
prepared using the RNeasy kit (QIAGEN). RNA was reverse-transcribed into cDNA using RT
Superscript III under the following conditions: 27 µl bulk RNA were incubated with 1 µl random
hexameric primers (300 ng/µl) and 0.5 µl dNTPs (25 nmol each) at 65 °C for 5 min and at 4 °C
Chapter 4. Materials & Methods 76
for 2 min. 8 µl 5x buffer were added together with 2 µl 100 mM DTT, 1 µl RNAsin (400 U/µl) and
1 µl Superscript III enzyme. The reaction was performed by incubating the mix 5 min at 25 °C
followed by 1 h at 50 °C and 15 min at 70 °C. cDNA was stored at 4 °C. Variable Ig regions were
amplified in a semi-nested PCR using cDNA as templates. After sequence identification of the
respective murine heavy (gamma) and light (kappa) chain variable region gene segments
(standard sequencing of PCR products, MWG), these segments were subcloned into plasmids
containing leader peptides and human constant regions for kappa and gamma1. This way,
full Ig heavy and light chains are expressed containing the murine epitope-specific region
joined to a human constant region. Assembly of both chains into a functional IgG1 takes
place during co-expression in vitro in HEK293T cells.
Transfection of HEK293 cells
8.5 µg of plasmid DNA (each kappa and gamma1 plasmids) per dish were used together
with a pAdvantage plasmid in 2 ml 150 mM NaCl solution with 3 µg of PEI per µg of DNA. The
mix was stirred for 10 sec, incubated for 10 min at RT and distributed evenly on the cells. Cells
were incubated for 3 days, supernatants were harvested and new DMEM + 1 % Nutridoma-
SP was added for a second harvest after additional 3 days. Secreted IgG1 was purified as
described below.
4.7 Microbiological & Biochemical Methods
4.7.1 Bacterial Lifestyle
S. flexneri strains were grown in TSB medium or on TSB agar plates supplemented with
0.2 % Congo Red. Antibiotics were used at concentrations given in table 4.9. E. coli were
grown in LB medium or on LB agar plates. Antibiotics were used as listed in table 4.9.
Table 4.9: Antibiotics and their concentrations.
Antibiotic Final concentration
Ampicillin 50 µg/ml
Carbenicillin 50 µg/ml
Chloramphenicol (E. coli) 34 µg/ml
Chloramphenicol (S. flexneri) 6 µg /ml
Kanamycin 50 µg/ml
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4.7.2 Electrocompetent cells
E. coli GC10 or BL21 were subcultured to mid-log phase and optical density (OD) of the
culture was measured by absorption at 600 nm (OD600 = 0.4-0.6) in LB medium and har-
vested by centrifugation at 10.000 rcf for 10 min at 4 °C. All subsequent steps were carried
out maintaining the bacteria on ice. The bacteria were washed twice with ice-cold ddH2O
and once with 10 % (v/v) glycerol (sterile filtered). The final pellet was resuspended in 1-2 ml
of 10 % (v/v) glycerol, aliquoted in 40 µl and immediately flash-frozen in liquid N2. Aliquots
were stored at -80 °C.
4.7.3 Transformation of bacteria
After thawing on ice, electrocompetent cells were transformed with either 50-100 ng of
plasmid DNA or 10 µl ligation reaction which has been dialysed against ddH2O for 10 min
using PVDF membrane floats with 0.22 µm pore size (Millipore). 40 µl of competent cells
were mixed with the DNA in a pre-cooled electroporation cuvette (Bio-Rad) and pulsed for
1 sec (200 Ω pulse-controller, 25 mF, 2.5 kV). Cells were immediately resuspended in 200 µl
LB medium and incubated at 37 °C under agitation. For re-transformation, 50 µl were plated
on LB agar plates with selective antibiotics. For ligations, the complete mix was plated on LB
agar plates with selection markers.
4.7.4 Secretion assay
Bacteria were grown over night and culture aliquots corresponding to an OD600 of 2/ml
(about 109 bacteria) were harvested and the supernatant was saved. Bacteria were washed
once with PBS and resuspended in 100 µl SDS sample buffer. The supernatant was filtered
(0.22 µm) and proteins were precipitated with 10 % (v/v) Trichloroacetic acid (TCA) for 5 min at
-20 °C and harvested subsequently by centrifugation at 16.100 rcf for 30 min at 4 °C. Pellets
were washed once with 1 ml ice-cold acetone and centrifuged again for 30 min. Acetone
was discarded directly after centrifugation and the pellets dried at room temperature and
resuspended in 10 µl 3 M TrisHCl, pH 8.5, plus 90 µl SDS sample buffer. Supernatants and
10 % of the equivalent bacterial lysates were analyzed by SDS PAGE and Western blotting.
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4.7.5 Induction of T3SS with Congo Red
Bacteria were grown in 25 ml TSB to mid-log phase (OD600 = 0.4-0.6) and harvested at
4.500 rcf for 10 min. Cells were washed with PBS and concentrated in 1 ml PBS supplemented
with 20 µg/ml Congo Red or just PBS in eppendorf tubes. The suspension was incubated under
agitation at 400 rpm for 1 h at 37 °Cand supernatants were filtered and precipitated with TCA
as described before.
4.7.6 SDS PAGE and Western blot
All SDS PAGE (except 2D-electrophoresis) were performed using TrisHCl gradient gels (Cri-
terion AnykD or 4-20 %, Bio-Rad) according to manufacturers instructions, or manually cast
12 % gels as previously described (Laemmli, 1970). Proteins were transferred on nitrocel-
lulose membrane (Amersham Hybond ECL, GE Healthcare) as previously described (Towbin
et al., 1979) with 2 mA/cm2 for 1 h and blocked with 5 % (w/v) milk powder in PBS-T for 30-
60 min. Proteins were detected using monoclonal antibodies (mABs) or polyclonal antibodies
(pABs) listed in table 4.10. Primary antibodies were incubated 1-16 h (1 h at RT or over night
at 12 °C), membranes were washed 3-4 times with PBS-T and secondary antibodies coupled
to horse radish-peroxidase were incubated for 30-60 min at RT. Visualization was performed
with enhanced chemiluminescence using ECL substrate (SuperSignal West, Thermo Scien-
tific) with a chemiluminescence detector cabinet or on film (Amersham Hyperfilm, GE Health-
care). The IpaB mAB was purified from the H16 hybridoma cell line (Barzu et al., 1993).
Table 4.10: Antibodies used in this study
Name Source
IpaB mouse IgG1 monoclonal H16 Armelle Phalipon
IpaB IgG1 human Fc monoclonal This study
IpaC rabbit polyclonal Institut Pasteur
DnaK mouse monoclonal Stressgen
MxiG mouse monoclonal 7G1 Lab collection
Strep-tag mouse monoclonal QIAGEN
anti-mouse goat HRP conjugate Dianova
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Name Source
anti-human goat HRP conjugate Dianova
anti-mouse goat Au conjugate 5 nm BBInternational
anti-mouse goat Au conjugate 12 nm BBInternational
anti-human goat Au conjugate 5 nm BBInternational
4.7.7 In-gel visualization of SDS PAGE
For regular staining, Coomassie stain or a commercial Coomassie Brilliant Blue G250-
based staining solution was used (Instant blue, Biozol). For silver staining, a rapid protocol
by Nesterenko et al. (Nesterenko et al., 1994) was adopted. The procedure is described
below in table 4.11.
Table 4.11: Rapid silver staining protocol.
Step Solutions used Duration
Fixing 60 ml acetone stock, 1.5 ml TCA stock, 25 µl 37 % (v/v)
HCHO
5 min
Rinse 3 x 50 ml ddH2O 10 sec
Wash 50 ml ddH2O 5 min
Rinse 3 x 50 ml ddH2O 10 sec
Pretreat I 60 ml acetone stock 5 min
Pretreat II 100 µl Na2S2O3 · 5 H2O stock in 60 ml ddH2O 1 min
Impregnate 800 µl AgNO3 stock, 600 µl 37 % (v/v) HCHO 8 min
Rinse 3 x 50 ml ddH2O 10 sec
Develop 0.6 g Na2CO3 ddH2O, 25 µl 37 % (v/v) HCHO, 25 µl
Na2S2O3 · 5 H2O stock in 60 ml ddH2O
10-60 sec
Stop 1 % (v/v) glacial acetic acid in 60 ml ddH2O 30-60 sec
Stock solutions:
Acetone stock (50 % (v/v) acetone in ddH2O); TCA stock: (50 % (v/v) TCA in ddH2O), 20 %
(w/v) AgNO3 (fresh each time, kept at RT in dark for short-term storage), 10 % Na2S2O3 · 5 H2O
in ddH2O.
4.7.8 Protein expression in E. coli BL21
Bacteria carrying the plasmid encoding the protein of interest were subcultured in 2-4 l
of LB medium to mid-log phase (OD600 = 0.4-0.6) and induced with either 0.5-1 mM IPTG (for
pET-vectors) or 0.5-1 µg/ml AHT for 2-3 h at 37 °C. Bacteria were harvested by centrifugation
at 10.000 rcf for 10 min and pellets were flash-frozen in in liquid N2. Pellets were stored at
-80 °C.
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4.7.9 Purifying proteins from heterologous expression
Protein purification from bacteria
IpaB-Knot or IpaB-Knot in complex with IpgC were purified as previously described (Lunelli
et al., 2009; Senerovic et al., 2012). E. coli BL21 co-transformed with pET28a::ipgC (with a 3’
6his-tag) and pASK-IBA3+::ipaBknot (with a 3’ strep-tag) were grown to early log-phase and
expression of ipgC was induced with 0.5 mM IPTG for 30 min. Then, expression of ipaBknot
or ipaB was induced with 0.7 µg/ml (w/v) AHT. Bacteria were opened using a French Pres-
sure Cell, 3 cycles with 10.000 psig and the lysate was collected on ice. Debris was removed
by centrifugation at 45.000 rcf for 20 min at 4 °C. IpgC and IpaB-Knot were co-purified us-
ing 5 ml HisTrap HP cartridges (GE Healthcare) according to manufacturers instructions. The
complex binds to the resin via IpgC and IpaB-Knot is eluted with 0.1 % (w/v) LDAO. For fluo-
rescence spectrometry and Proteinase K digestion, full complex of IpgC/IpaB-Knot was eluted
with 0.5 M imidazole. Additional affinity chromatography in the presence of 0.05 % LDAO us-
ing 5 ml Strep-Tactin columns (IBA) was performed to separate full length IpaB-Knot from
IpaB contaminants which might occur because of instability of the fusion protein. Native pro-
tein was separated from aggregates by size exclusion chromatography using a Superdex 200
16/60 column (GE Healthcare) with 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES), pH 7.4, and 150 mM NaCl. The knot was expressed with a C-terminal His-tag (pASK-
IBA33+::knot) in E. coli BL21 and purified via a 5 ml HisTrap HP column in 20 mM TrisHCl,
pH 7.4, 300 mM NaCl, 1 mM DTT, 40 mM Imidazole and eluted with 400 mM Imidazole under
same buffer conditions. Proteins were concentrated to 1-2 mg/ml using Amicon spin-filters
with appropriate molecular weight cut-off.
IgG purification from HEK293 cells
Supernatants from HEK293 cells (25 ml each dish) were collected and incubated over
night with 50 µl Protein G sepharose with gentle rotation at 12 °C. The mixture was passed
over an empty Poly-Prep column (Bio-Rad) and washed with 3 x 1 ml PBS. Residual PBS was re-
moved with gentle air pressure. IgG1 was eluted under acidic conditions with 225 µl 100 mM
Glycine pH 3.0 incubated for 5 min on the column bed and elution volume was collected in
eppendorf cups with 25 µl 1 M Tris pH 8.0, 0.1 % (w/v) sodium azide. Elution of IgG1 was re-
peated three times and the protein concentration was measured using the NanoDrop 2000
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IgG analysis program. The antibody was concentrated to 2 mg/ml.
4.7.10 Fluorescence spectroscopy
Purified protein (either IpaB-Knot in complex with IpgC or Knot) was used at 2.5 µM con-
centrations at 25 °C in quartz cuvettes (Helma). Samples were excited with 295 nm monochro-
matic light using 2.5 nm or 5 nm slit-width. Detector voltage was set to 650 V. Emission spec-
tra were recorded ranging from 300 to 400 nm at a slit-width of 5 nm or 10 nm. Control
emission spectra (buffer with IpgC as a control for IpaB-Knot in complex with IpgC) were
subtracted from sample protein spectra. Emissions were normalized to their respective max-
imum.
4.7.11 Limited proteolysis and mass spectrometry (MS)
Mass spectrometry and 2D-electrophoresis (2D-E) were performed by the Protein analysis
core facility, MPIIB Berlin. Purified IpaB-Knot in complex with IpgC or Knot were treated with
Proteinase K at a molar ratio of 1:100 (enzyme to substrate) for 1 h at room temperature. The
reaction was stopped by adding complete EDTA-free protease inhibitor cocktail (Roche) and
the cleavage products were separated by 2D-E (Jungblut & Seifert, 1990). Respective pro-
tein cleavage products were trypsinated and analyzed by MS, whereas fragments of specific
interest were confirmed by MS/MS.
4.7.12 Isolation of needle complexes
Needle complexes were isolated from bacteria as described previously (Blocker et al.,
2001). 2 L of bacterial culture were inoculated 1:50 and grown to an OD600 of 1.2-1.6/ml
and washed once with PBS. Cells were osmotically shocked by resuspension in 0.5 M sucrose.
0.1 M TrisHCl, pH 8.0 and 5 mM EDTA were added. Bacteria were incubated in the presence of
1-2 mg lysozyme (Novagen) for 30-60 min and lysed with 2 % (v/v) Triton X-100. Debris was
removed by centrifugation for 20 min at 45.000 rcf and needle complexes were harvested by
pelleting the supernatant at 110.000 rcf for 1 h. The pellet was washed in 10 mM TrisHCl pH
8.0, 150 mM KCl, 5 mM EDTA, 1 % (v/v) Triton X-100 and 0.3 % (w/v) Sarkosyl. Centrifuga-
tion steps were repeated and pelleted needle complexes were resuspended in 1-2 ml 50 mM
TrisHCl, pH 8.0, 50 mM EDTA, 0.1 % Triton X-100 (TET buffer).
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Cesium chloride density fractionation
Needle complexes were further separated by CsCl gradient centrifugation (27.5 % (w/v)
CsCl in TET) and size exclusion chromatography (Superose 6 16/60, GE Healthcare, in TE
buffer). The solubilized needle complexes in TET were supplemented with 27.5 % (w/v) CsCl
and the volume adjusted to 6 ml. The sample was centrifuged in a MLS-50 swing-out rotor at
50.000 rpm (Beckman Optima MAX) overnight (14 h). Aliquots of 500 µl each were carefully
removed from top to bottom and diluted in 2.5 ml TE buffer. Needle complexes were concen-
trated by ultracentrifugation (100.000 g, 1 h, 4 °C), the pellet resuspended in 100 µl TET and
subjected to size-exclusion chromatography on a Superose 6 10/300 column (GE Healthcare).
Needle complexes eluted in the void volume of the column (7-8 ml) and 1 ml fractions were
concentrated by ultracentrifugation at 100.000 g for 1 h at 4 °C. Sample volume was adjusted
to 3 ml with TET buffer prior to centrifugation. After pelleting, supernatants were discarded
and the needle complexes carefully resuspended using a cut yellow tip in 20-40 µl TET buffer
avoiding foam formation.
Affinity purification
Affinity purification of needle complexes via Strep-Tactin sepharose (IBA) in TET was per-
formed by interaction of the C-terminal Strep-tag of IpaB-Knot. Strep-Tactin resin was used
for batch purification of needle complexes interacting with IpaB-Knot. Needle complexes sol-
ubilized in TET buffer were added to 100-150 µl Strep-Tactin 50 % suspension and incubated
with gentle rotation at 12 °C for 1 h. The saturated beads were washed 3 times (centrifuga-
tion at 2000 rcf for 2 min and careful removal of the supernatant using a pipet) with 1 ml TET
buffer and collected on a Pierce centrifuge column by gravity flow. Subsequently, the beads
were treated with 50 µl TET + 10 mM desthiobiotin and incubated for 10 min prior to elution.
Needle complexes were eluted by centrifugation at 2000 rcf for 2 min and the elution step
was repeated with additional 50 µl TET + desthiobiotin.
4.7.13 TEV protease protection assay
Isolated needle complexes or recombinant IpaB-TEV-Knot in complex with IpgC was added
to 100 µl Strep-Tactin beads (IBA) and incubated for 1-2 h at 4 °C with gentle rotation (12-
15 rpm). Beads were washed twice with 500 µl TET buffer and subsequently washed twice
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with 1 ml 50 mM Tris, pH 8.0, 0.5 mM EDTA, 1 mM DTT (TEV assay buffer) and finally resus-
pended with 100 µl TEV assay buffer. 4 aliquots of 40 µl bead slurry were adjusted to room
temperature and subsequently incubated with either 10 µl TEV assay buffer (negative con-
trol), 0.1 µg, 1 µg or 10 µg TEV protease at 400 rpm at 26 °C. The beads were collected by
centrifuging at 2000 rcf for 2 min. 30 µl aliquots of supernatant were collected and supple-
mented with SDS sample buffer. The bead fraction was washed 2 times with 1 ml TEV assay
buffer and the beads resuspended in 30 µl TEV assay buffer and supplemented with SDS
sample buffer. Samples were analyzed by SDS PAGE and Western blotting.
4.7.14 Addition of PEG moieties by crosslinking (PEGylation)
Engineered PEG molecules that contain an N-hydroxysuccinimide (NHS) ester group can
be linked to free primary amines in proteins by a spontaneous formation of an amide bond
and releasing the NHS. For PEGylation of IpaB-TEV-Knot, isolated needle complexes (with
IpaB-TEV-Knot) or purified IpaB-TEV-Knot were added to 100 µl Strep-Tactin resin (IBA) and
incubated for 1-2 h at 4 °C with gentle rotation (12-15 rpm). Beads were washed twice with
500 µl TET buffer and subsequently washed twice with PBS and finally resuspended with 50 µl
PBS. 2 aliquots of 40 µl bead slurry were adjusted to room temperature and subsequently
incubated with 0.5 mM PEGylation reagent MS(PEG)24 (Thermo Scientific) for 1 h at room
temperature. The reaction was quenched by addition of 100 mM TrisHCl for 5 min at room
temperature and the reaction was directly incubated with SDS sample buffer and analyzed
by SDS PAGE and Western blotting.
4.8 Imaging & Bioinformatics
4.8.1 Immuno-electron Microscopy (iEM)
Staining of samples and image acquisition were performed by Christian Goosmann at the
Microscopy core facility, MPIIB Berlin.
10 µl aliquots of the needle complex preparations were applied to freshly glow-discharged
carbon- and pioloform-film-coated copper grids and allowed to adsorb for 10 min. The grids
were then washed with PBS, blocked for 15 min and then incubated with human or mouse an-
tibody against IpaB for 2-3 h at RT. After washing with PBS the samples were incubated with
goat anti-mouse antibody adsorbed to 12 nm gold particles or goat anti-human antibody ad-
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sorbed to 6 nm gold for 30 min and washed with PBS. Strep-tag labeling was done in a similar
manner but using mouse anti-Strep-tag antibody and goat anti-mouse antibody adsorbed to
12 nm gold. For double-labeling of both IpaB and Strep-tag, IpaB was labeled first with hu-
man anti-IpaB and the matching secondary antibody followed by labeling of the Strep-tag. In
this case, the Strep-tag antibody was incubated over night followed by secondary antibody
incubation.
After three washes with distilled water, the grids were contrasted with 4 % phospho-
tungstic-acid (PTA), 1 % Trehalose, pH 7.0, or NanVan, touched onto filter paper and air-dried.
The grids were examined in a LEO 906 transmission electron microscope (Zeiss AG) operated
at 100 kV and images were recorded with a Morada (SIS-Olympus) digital camera.
4.8.2 Nearest-neighbor analysis
Coordinates (X and Y) for gold labels and needle complex centers from 50 iEM images
(2048x2048 px2) were manually obtained using the ImageJ analysis package (Abramoff et al.,
2004). The values were processed in R (R Development Core Team (2003)) and subjected to
a nearest-neighbor analysis with the Biobase package (Gentleman et al., 2004). Coordinates
of needle complex centers were matched with coordinates of the closest gold particle co-
ordinates. As a control, random coordinates of needle complexes and gold particles were
generated and used in comparison to the manually obtained coordinates. This way, exact
counts per image were maintained.
4.8.3 cryo-electron microscopy (cryo-EM)
The procedures described below were performed in close collaboration with Jörg Bürger
and Thorsten Mielke, MPI for Molecular Genetics, Berlin. Electron microscopy at near-liquid
nitrogen temperatures was performed on vitrified isolated needle complexes in TE buffer with
0.02 % Triton-X100 or 0.4 % OG.
Sample preparation for cryo-EM
Holey carbon grids (300 mesh R3/3 Quantifoil® Cu grids, Quantifoil Micro Tools GmbH)
layered with 2 nm of carbon film were glow-discharged for 30 sec and used directly after the
discharging procedure. 3.5 µl of sample were loaded on holey film grids and adsorbed for
45 sec in a Vitrobot Mark II device (FEI) at 4 °C and 100 % humidity. The grid was blotted for
Chapter 4. Materials & Methods 85
4 sec and plunge-frozen in liquid ethane at 77 K. Grids were kept at ultra-low temperatures at
all times after freezing.
cryo-EM imaging
Grids were analyzed with a Tecnai™ G2 Spirit transmission electron microscope together
with a 2 k Eagle 4 Mpx CCD™camera (both FEI) operated at 120 kV (LaB6 cathode). Objective
and C2 apertures were set to 100 µm. Images have a final resolution of 2048px x 2048px at a
nominal magnification of 30,000-fold, resulting at a pixel size of 7 Å relative to the specimen
scale. The Leginon system (Suloway et al., 2005) was used for automated image collection.
4.8.4 Single particle-analysis
Single particle-analysis was performed with Elmar Behrmann, Institut für medizinische
Biophysik, Charité Berlin. Particles were selected semi-automatically using EMAN2 (Tang
et al., 2007) after evaluation of the contrast transfer function using CTFFIND3 (Mindell &
Grigorieff, 2003). From projection images of the selected particles, 2D class averages were
calculated using the SPARX software package (Hohn et al., 2007).
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6.1 Abbreviations
General abbreviations
α alpha
β beta
∆ gene deletion mutant
A adenine
APS ammonium persulfate
ATP adenosine triphosphate
bp base pair
BSA bovine serum albumin
C cytosine
C-terminus carboxy terminal end of polypetide or protein
Da Dalton (molecular weight unit)
DMEM Dulbeccos modified Eagle medium
DNA desoxyribonucleic acid
EDTA ethylene diamine tetraacetate
FCS fetal calf serum
FPLC fast performance liquid chromatography
G guanine
HEK human embryonic kidney (cell line)
HEPES 2-[4-(2-hydroxyethyl)-1-piperazino]-ethansulfonic acid
Inv invasion
Ipa invasion plasmid antigen
IpgC invasion plasmid gene C
IPTG isopropyl thiogalactoside
kb kilo base
kDa kilo Dalton
LB lysogeny broth (medium)
MALDI matrix assisted laser desorption/ionization
MOI multiplicity of infection
MS mass spectrometry
Mxi membrane expression of invasion
N-terminus amino terminal end of polypetide or protein
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General abbreviations
NC needle complex
OD optical density
PAGE polyacrylamide gel electrophoresis
PCR polymerase chain reaction
PBS phosphate-buffered saline
PDB Protein Data Bank
PEG polyethylene glycol
PFA para-formaldehyde
pI isoelectric point
psi pressure unit, Pascal
rcf relative centrifugal force
rpm revolution per minute
RT room temperature
SDS sodium dodecylsulfate
SEC size exclusion chromatography
Spa surface presentation of antigen
T thymine
TCA trichloroacetic acid
TEMED N,N,N’,N’-tetramethylethylenediamine
TRIS Tris(hydroxymethyl)-aminomethane
T3SS type three secretion system
wt wildtype
Yop Yersinia outer protein
Ysc Yersinia secretion
Amino acids
G Glycine (Gly) W Tryptophan (Trp)
P Proline (Pro) H Histidine (His)
A Alanine (Ala) K Lysine (Lys)
V Valine (Val) R Arginine (Arg)
L Leucine (Leu) Q Glutamine (Gln)
I Isoleucine (Ile) N Asparagine (Asn)
M Methionine (Met) E Glutamic acid (Glu)
C Cysteine (Cys) D Aspartic acid (Asp)
F Phenylalanine (Phe) S Serine (Ser)
Y Tyrosine (Tyr) T Threonine (Thr)
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6.2 Sourcecode for R: Nearest-neighbor analysis
require(Biobase)
# Set parameters
config .image. size .x <− 2045
config .image. size .y <− 2045
config . factor .nm_per_pixel <− 200/176
config . histo . breaks <− 50
config .path<−"#folder with images"
# Define functions
simulate . events <− function (events ){
matrix(
trunc(
runif (events*2) * c( config .image. size .x , config .image. size .y)
) ,
ncol=2,
1 byrow=TRUE
)
}
f i l e s . input <− l ist . f i l e s ( config .path, pattern=" . * txt$" )
l ist . input <− lapply ( f i l e s . input , function ( f i le . in )
{read .csv(paste( config .path, f i le . in , sep="" ) ,sep="" ,header=TRUE) })
data . coord_dist <− sapply( l ist . input , function (data . input ){
pos. needle <− data . input [data . input$Type==1,c( "X" , "Y" ) ]
pos. gold <− data . input [data . input$Type==2,c( "X" , "Y" ) ]
pos. needle<−matrix(as .double(c(pos. needle$X,pos. needle$Y) ) ,ncol=2,
dimnames=l ist (NULL,colnames(pos. needle) ) )
pos. gold<−matrix(as .double(c(pos. gold$X,pos. gold$Y) ) ,ncol=2,dimnames=
l ist (NULL,colnames(pos. gold ) ) )
count . needle <− dim(pos. needle) [1]
count . gold <− dim(pos. gold ) [1]
# Find nearest neighbors (nn)
nn. gold . needle <− matchpt(pos. gold ,pos. needle)
nn.segments <− cbind(pos. gold ,pos. needle[nn. gold . needle$index , ] )
l ist (nn. gold . needle$distance ,pos. needle [ , "X" ] ,pos. needle [ , "Y" ] ,pos. gold
[ , "X" ] ,pos. gold [ , "Y" ] ,c(count . needle ,count . gold ) )
})
histo .data . l i n <− hist (unlist (data . coord_dist [1 , ] ) *config . factor .nm_per_
pixel , breaks=config . histo . breaks , plot=FALSE)
histo .data . log <− hist ( log (unlist (data . coord_dist [1 , ] ) *config . factor .nm_per
_pixel ,10) , breaks=config . histo . breaks , plot=FALSE)
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data . simulation <− replicate (50 ,sapply(data . coord_dist [6 ,] , function ( counts_
needle_gold ){
matchpt(
simulate . events (counts_needle_gold [2]) ,
simulate . events (counts_needle_gold [1])
)$distance
}) )
histo . simulation . l i n <− hist (unlist (data . simulation )*config . factor .nm_per_
pixel , breaks=config . histo . breaks , plot=FALSE)
histo . simulation . log <− hist ( log (unlist (data . simulation )*config . factor .nm_
per_pixel ,10) , breaks=config . histo . breaks , plot=FALSE)
#output
postscript ( f i le="P: / foo .ps" ,paper="a4" )
par(mfrow=c(2 ,1) )
plot ( histo .data . log ,
xlim = range( histo .data . log$breaks , histo . simulation . log$breaks) ,
xlab = "Distance (nm) " ,
ylab = "Counts" ,
col = "00000080" ,
freq = FALSE,
main = " Distribution of nearest neighbors"
)
plot ( histo . simulation . log ,
col = "#80808080" ,
freq = FALSE,
add = TRUE
)
legend( " topright " ,
c( "Data" , "Simulation" ) ,
f i l l = c( "black" , "darkgrey" ) ,
bty = "n" ,
border = NA
)
dev. off ( )
